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ABSTRACT 
Purpose: Current literature reports that between 7 and 14% of young, healthy women have stress 
urinary incontinence (SUI). No gold standard exists for quantifying urine leakage, although pad 
tests have been used in older, parous populations. The aim of this study was to determine the 
reliability and accuracy of a new pad test for young, healthy women with SUI. Methods: The 
pad test consisted of measuring quantity of leakage after the following activities: stair running, 
standing up from sitting, curl-ups, running on the spot, jumping jacks, jumping on a mini-
trampoline and coughing vigorously. Bladder volume was standardised by having the volunteers 
drink one litre of water one hour prior to the testing. The volunteers performed the pad test on 
two consecutive days. Results: Sixteen nulliparous women between the ages of 18 and 30 years 
(7 controls and 9 with SUI) participated in this study. The mean increase in pad weight was 0.64 
g (± 0.50) in the continent group and 11.89 g (± 20.32) in the group with SUI. There was no 
significant difference in pad weight between the testing sessions (p=0.228), however the test was 
not able to elicit measureable urine loss in 3 participants with SUI. Pad weights between the two 
groups of women were significantly different (p=0.023). The test re-test ICC for the continent 
group was 0.845 (95% CI: 0.139–0.973) and 0.782 (95% CI: -0.040–0.952) for the group with 
SUI.  Significance: The results of this study support the use of this pad test in healthy young 
women with SUI; it appears to be reliable and challenging enough to cause measureable urine 
loss in the majority, and it may be useful for diagnosing and quantifying SUI without 
urodynamic studies.
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CHAPTER 1 
INTRODUCTION 
Urinary incontinence (UI), defined by the International Continence Society as “any 
involuntary leakage of urine,”1 is experienced by at least 50% of women at some time in their 
lives.2 There are several types of UI, the most prevalent is stress urinary incontinence (SUI):3,4 
defined as “any leakage on effort or exertion, or on sneezing or coughing.”1 
SUI in young, healthy, nulliparous women was first reported in the literature in 1954. Nemir 
and Middleton5 found that 695 of 1,327 (52.4%) female, nulliparous university students between 
the ages of 17 and 21 years reported via questionnaire  to occasional (49.7%) or frequent (2.6%) 
SUI. In 1969, Wolin reported similar results with a sample of 4,211 nulliparous nursing students 
between the ages of 17 and 25 years. He found that 2,135 (50.7%) had some degree of SUI, with 
1,451 (34.5%) experiencing occasional and 684 (16.2%) experiencing daily leakage.6 More 
recent studies have reported prevalences of SUI in young women that range between 3.7% and 
14%.4,7-12 The prevalence of SUI in physically active young women rises to 49% in college 
athletes13 and 19-31% 14-17 of women in military training or in the armed forces.  
The negative effects of UI on quality of life have been widely reported in the literature;3,12,18-23 
however the majority of the studies do not differentiate between types of UI. Social, work and 
sexual activities can all be affected by UI.18,22,24,25 Women with UI may limit their social lives by 
avoiding leaving the house for long periods,20 considering quitting their sport,21 restricting their 
activities, including work, and limiting fluid intake to prevent leakage.12,19,22 Younger women 
with UI demonstrate greater activity restrictions than do older women with the same UI 
severity.19,22 In a study assessing the impact of UI on the sex lives of women and their partners, 
22% of men and 43% of women stated that the woman’s urinary problems impaired their sexual 
life.24 Forty-nine percent of the women worried about leaking during sexual activity and 14% 
thought that their ability to reach orgasm had decreased secondary to UI.  
Higher rates of anxiety and depression in women with UI have been well-
documented.3,12,19,22,26-28 Young women with UI have lower psychological well-being than those 
without leakage.12 Sixteen percent of women with UI under the age of 30 consider their urinary 
leakage to be extremely embarrassing or humiliating,20  and half of young, nulliparous women 
with UI between the ages of 16 and 30 worry about odour.12 In a Canadian study, the prevalence 
of major depression in women with UI (15.5%) was significantly greater than in women without 
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UI (9.2%), with an odds ratio of 5.73 (95% CI: 3.11-10.54) for having major depression in the 
presence of UI.26 This association was found to be even stronger in the youngest age-group (18-
44 years), a finding that has been supported by the literature.19,22 In addition, the percentage of 
Canadian women with UI and depression expressing excellent general health (15.1%) was 
significantly lower than those with only UI (59.2%).26 The percentage who reported being “quite 
a bit” or “extremely” stressed (Health Utility Index, Mark III) was also significantly different 
between the two groups (61.6% of women with comorbid UI and depression versus 26.6% of 
women with UI who were not depressed). Taken together, this research suggests that UI can lead 
to behavioural, psychological and health concerns, far beyond the symptom of the urine leakage 
itself. 
1.1 Aetiology of SUI in Young Women 
To maintain continence, urethral closure pressure must be greater than bladder pressure, 
both at rest and with activity, and independent of the volume of urine in the bladder.29 It is well-
established that the endopelvic fascia (connective tissue), pelvic floor muscles (PFMs), striated 
urethral sphincter and neuromuscular control all contribute to the continence mechanism.29,30 
This system is disrupted in women with SUI, but the mechanisms behind the disruption are not 
well understood. It has been widely assumed that SUI develops as the result of trauma sustained 
during vaginal delivery.9,11,31,32 Indeed, elective Caesarian sections are now being performed 
with the sole purpose of avoiding incontinence.33 However, this does not explain the common 
occurrence of SUI in young, nulliparous women,4-11 and there is little research in this population. 
Factors associated with SUI in young, nulliparous women include increased body mass 
index (BMI),32,34,35 high impact physical activity,13-17,34,36-39 oral contraceptive use,40,41 sexual 
activity,12 smoking,11,35,42,43 a history of urinary tract infections (UTIs),10,32 and chronic 
constipation.9,32,44 Genetic traits, such as connective tissue composition, have also been 
suggested as potential factors.16,45-48 Currently, the most robust models based on studies of twins 
suggest that SUI in young women is the result of equal parts genetic predisposition and 
environmental factors.49 
1.2 Measurement 
Given the high prevalence and the frequently negative implications of SUI in young 
women, it is essential for both clinicians and researchers to have methods to objectively measure 
urine loss in this population in order to effectively assess and manage the condition. Leakage 
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severity has been quantified in five different ways: with patient-reported outcome (PRO) 
questionnaires, bladder diaries, urodynamic testing, cough stress tests, and pad tests.50,51  
PRO questionnaires and bladder diaries are used to record the individual’s perception of 
their urine leakage, but the tools are not able to measure the quantity of urine lost and 
individuals’ estimates of leakage volume will be subjective.51 In addition, some have been shown 
to be inapplicable for women who have not been diagnosed using urodynamics.52 There is also 
disagreement in the perceived value of PROs, with some suggesting that they are no better than a 
clinical history,53 and others arguing that they offer a complementary and independent role in a 
comprehensive assessment for SUI.54 While bladder diaries are used extensively in the literature, 
to date no diary has been scientifically validated. Some argue that a diary provides no more 
information than a clinical history,55 but others suggest that if a diary has been correctly 
completed, it can reduce recall bias.56  
Urodynamic testing and cough stress testing are both done in the specialist’s office and 
involve the artificial filling of the bladder via a catheter. Urodynamic testing is an invasive 
functional study of the lower urinary tract, requiring the insertion of catheters into the urethra, 
bladder and rectum.50,57 It is used to diagnose a variety for lower urinary tract disorders, 
including SUI. A cough stress test is a simple test to assess for SUI. It requires the woman to 
cough forcefully with a full bladder, while the investigator or clinician watches for urine leakage 
from the urethra.58-60 Both tests permit the clinician or researcher to observe whether urine 
leakage occurs under certain conditions;50,51 however, the amount of leakage can only be 
measured with the modified cough stress test (paper towel test).59,61 Urodynamics are 
expensive,62 and many of the parameters have yet to be properly standardised, are poorly 
reproducible, and are not able to contribute to the differential diagnosis or to detect minimally 
important changes.62-66 The International Continence Society recommends that such invasive 
studies are not necessary when the type of UI is clear and the planned treatment is reversible.50 
Cough stress tests are simple to use but do not correlate well with patient-reported symptoms,67 
and patients find these tests to be embarrassing to perform.68  
The objective of pad testing is to quantify the volume of urine lost by weighing an 
absorbent pad before and after some type of leakage provocation.69 Only pad tests are able to 
quantify the volume of urine lost during activity. There are two types of pad test: home-based 
and office-based. The home-based tests serve to assess urinary leakage while the woman 
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performs her daily activities, and typically takes place over 24 to 48 hours. The office-based pad 
test, on the other hand, involves the participant performing standardised physical activities in a 
clinical setting for a period up to one hour.51 Office-based pad tests are inexpensive, non-
invasive, can be standardised, and are reproducible.70 Although SUI is prevalent in young, 
healthy women, the pad tests that have been reported in the literature have been developed for 
and validated in the older, parous population.71-80  
Each of the five methods for assessing leakage severity has problems with reliability and 
validity so, to date, there is no gold standard for measuring the severity of SUI or changes in 
leakage with treatment.53  
1.3 Purpose 
It has been established that reliable, repeatable means of evaluating urinary incontinence 
are required to objectively assess and treat women with SUI. With health care costs soaring 
world wide, clinicians are seeking inexpensive assessment tools that can be used in a primary 
care setting.53 The World Health Organization and the International Continence Society 
recommend pad testing as a method to detect and quantify urine loss.51 Our preliminary study, 
based on pad tests from two research studies that included women under the age of 30,81,82 
revealed that these tests were not provocative enough to elicit urine loss in young, nulliparous 
women with SUI (Appendix A). In order to adequately quantify SUI in women between the ages 
of 18 and 30 years, a new test, one more provocative than other pad tests, is required. The 
purpose of this pilot study was to determine the reliability of a new, standardised pad test 
designed specifically to assess urine leakage in young, healthy women with SUI.  
1.4 Hypothesis 
It was hypothesized that this new pad test would demonstrate good reliability83 and accuracy 
in young, healthy women with and without SUI between the ages of 18 and 30 years. 
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CHAPTER 2 
LITERATURE REVIEW 
In order to fully understand the complicated nature of SUI and to be able to assess it properly, 
it is necessary to first examine the normal anatomy and physiology of the continence system. 
Then, exploring the aetiology of SUI will reveal the many potential deficits in the continence 
mechanism. The examination of the environmental and familial risk factors for SUI in young, 
nulliparous women will further the understanding of how SUI might develop in this population. 
Finally, discussing the various methods currently available to measure the symptoms of SUI will 
provide the background for the development of a new pad test for healthy women between the 
ages of 18 and 30 years.  
2.1 Lower Urinary Tract Anatomy and Physiology 
2.1.1 Bladder 
The main function of the lower urinary tract is to store and excrete urine. Urine is 
continuously excreted from the kidneys and is delivered to the bladder via the ureters. The 
bladder stores the urine until there is a convenient, socially appropriate time and place to 
evacuate. The bladder outlet is in the inferior corner of the bladder and is comprised of the 
bladder neck, urethra and urethral sphincter (Figure 2.1). 
 2.1.1.1 Bladder anatomy 
The bladder is a multi-layered hollow sack whose walls are made up of four layers: the 
urothelium or lining, the lamina propria, the detrusor and the outer serosal layer.83 The 
urothelium is essentially water-tight, having a very low permeability to urine and pathogens.83 
The lamina propria is comprised of collagen and elastin, which affects passive wall tension.83 
The detrusor is smooth muscle making up 60-70% of the bladder wall thickness, with muscle 
cells arranged in longitudinal and circumferential layers, varying in orientation and thickness.83,84 
During filling the detrusor is relaxed, and with micturition it contracts to push the urine out 
through the urethra.85 The outer serosal layer, comprised of mesothelium and connective tissue, 
is part of the peritoneum and covers the superior aspect of the bladder.84
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Figure 2.1: Schematic diagrams of female bladder and urethra in sagittal section (A) and coronal section (B). 
(1) Pubic symphysis/rami; (2) posterior pubo-urethral ligaments; (3) intrinsic striated muscle; (4) intrinsic smooth 
muscle; (5) mucosa and submucosal vascular tissues; (6) smooth muscle of detrusor/deep trigone; (6’) smooth 
muscle of superficial trigone (7) extrinsic striated muscle/levator ani. From: Keane, D. P. and S. O'Sullivan (2000). 
"Urinary incontinence: anatomy, physiology and pathophysiology." Best Practice Research Clinical Obstetrics & 
Gynaecology 14(2): 207-226. 
 
The trigone, the triangular area that forms the base of the bladder, differs in embryological 
origin from the rest of the bladder and is the only area of the bladder in which this basic structure 
differs.86 Its three corners are comprised of the two ureteric openings superiorly through which 
the urine arrives from the kidneys, and the urethra inferiorly through which urine is expelled.84 
Trigonal muscular composition differs from that of the detrusor by having smaller myocytes in 
smaller muscle bundles and a greater percentage of connective tissue. The trigonal muscle is 
continuous with the smooth muscle of the ureters and the urethra, and is backed by the outer 
longitudinal and middle circular smooth muscle layers of the detrusor.83,84 
The trigone plays a crucial role in bladder filling, continence and micturition. The continuity 
of smooth muscle from the ureters with the trigone helps to prevent urinary reflux into the 
ureters.83,86 Muscarinic receptors in the trigone may also help to prevent urinary reflux into the 
ureters during involuntary detrusor contractions by facilitating a synergistic mechanism that 
produces an even stronger contraction of the interureteric muscle.83 During the filling phase, the 
trigone receives input from the sympathetic nervous system that stimulates the trigonal and 
internal urethral smooth muscle to contract, via alpha-adrenergic receptors, in order to keep the 
internal urethral opening closed and maintain continence.83,86 During micturition, the trigone acts 
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as a stable structure on which the dome of the bladder can contract; it is also believed to relax 
and cause a funneling of the bladder base into the urethra to facilitate voiding.83 
2.1.1.2 Neurological control  
The bladder differs from other visceral structures in a two ways. First, unlike cardiovascular 
organs, which have a tonic pattern of activity, the bladder functions under phasic control with 
only two modes: storage and elimination. Second and most significantly, bladder control is a 
learned behaviour, necessitating maturation of the nervous system, whereas other organs are 
regulated involuntarily.87  
Due to voluntary control of micturition, the storage and periodic emptying of urine is 
controlled by a complex neural system located in the brain, spinal cord and peripheral ganglia.87 
Storage reflexes occur primarily at the level of the spinal cord, whereas voluntary micturition is 
organized within the brain. Neurons in the pontine micturition centre, periaqueductal grey, 
caudal and preoptic hypothalamus and several parts of the cerebral cortex, especially the medial 
frontal cortex are all involved in the control of the bladder, urethra and urethral sphincter.87  
The pelvic plexus contains both parasympathetic and sympathetic innervation to the bladder. 
The parasympathetic innervation primarily controls the voiding stage and its motor nerves 
originate from the anterior sacral roots of S2-S4 and course through the pelvic splanchnic nerves. 
Parasympathetic postganglionic nerves release both acetylcholine and non-adrenergic, non-
cholinergic neurotransmitters. Cholinergic transmission serves to initiate the contraction of the 
detrusor muscle, allowing voiding to occur. Non-cholinergic contraction is mediated by ATP in 
the detrusor muscle. Urethral and trigonal smooth muscle inhibition is mediated by nitric oxide, 
released by the parasympathetic nerves, permitting relaxation of the smooth muscle to assist with 
bladder emptying.83,87 The sympathetic system is primarily responsible for urine storage, with 
fibres from T10-L2 travelling through the superior hypogastric plexus to the pelvic plexus.84,86-88 
Sympathetic postganglionic nerves release noradrenaline, activating β-adrenergic inhibitory 
receptors in the detrusor muscle to relax the bladder. They also have an excitatory effect on α-
adrenergic receptors in the urethra and bladder neck causing them to contract, thus facilitating 
urine storage.83,87 
Sensory information from the bladder is also transmitted by the autonomic nervous system. 
Sacral visceral afferent fibres are distributed in the detrusor muscle and submucosa, allowing the 
sensations of touch, pain and bladder filling to be interpreted by the brain.86 Sensations of 
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bladder distension are conveyed to the spinal cord via the pelvic and hypogastric nerves, whereas 
sensory input from the bladder neck travels along the pudendal and hypogastric nerves.87 A 
sensory plexus within the suburothelial layer, which is more prominent at the bladder neck and 
quite sparse at the dome of the bladder, is believed to convey the sensory information from the 
urothelium. In addition, non-neuronal sensory cells in the urothelium possess signaling 
properties that permit the response to chemical and mechanical stimuli. These cells are able to 
communicate reciprocally with the nerves within the bladder wall.87 
2.1.2 The Continence Mechanism 
The continence mechanism is divided into intrinsic and extrinsic components. The intrinsic 
portion is comprised of the urethra: with an inner mucosa, vascular plexus, and smooth muscle 
layers, and the surrounding striated urethral sphincters,89 all of which  contribute equally to 
resting urethral closure pressure.29,90 The extrinsic mechanism is made up of the pelvic floor 
muscles (PFMs) and fascial supports.90,91 This mechanism serves to close the urethral, vaginal 
and rectal openings, as well as to support the pelvic organs.29,92,93 
2.1.2.1 Intrinsic mechanism 
The urethra passes from the bladder base, through the PFMs, until it emerges onto the 
perineum, ventral to the vaginal opening. The urethral lumen is surrounded by epithelium and 
possesses a substantial vascular bed within the submucosa (Figure 2.2). The vascular plexus 
contributes to coaptation, forming a hermetic seal.29,85,86,91 Beyond the submucosa lie two layers 
of smooth muscle: an inner longitudinal layer and an outer circular layer. The function of the 
longitudinal smooth muscle is not known, but has been hypothesized to shorten the urethra83 and 
assist with opening the lumen during micturition.29 The outer circular layer occludes the lumen 
to assist with urine storage.29,83,84 As the urethra passes through the bladder neck, the detrusor 
muscle fibres travel along it for the first 15%, forming a U-shaped loop around the urethra that 
creates an internal sphincter and assists with closure.29 While present in all men, this sphincter is 
absent in many women.94 As in the bladder, the urethral sphincter system is innervated by the 
autonomic nervous system, originating in the pelvic plexus.89 The sympathetic fibres contract the 
smooth muscles of the urethra, inhibiting urine outflow.83,86,88 To allow micturition, 
parasympathetic nerve fibres relax the urethral smooth muscles, especially in the proximal 
portion.88 
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Figure 2.2: Midsaggital section through the urethra. 
From: Ashton-Miller, J. A. and J. O. L. DeLancey (2007). Functional Anatomy of the Female Pelvic Floor. Annals 
of the New York Academy of Sciences 1101(1): 266-296. (©Delancey, 1997) 
 
The circular fibres of the striated urethral sphincter begin where the detrusor muscle fibres 
end and extend down the middle third of the urethra.29 The striated sphincter is innervated by the 
perineal branches of the pudendal nerve (S2 to S4) and is comprised primarily of slow-twitch 
fibres, these produce constant tone to maintain continence and phasic increases in contraction 
force as required, to resist increases in intra-abdominal pressure.86,95 
Halfway down the urethra, the striated muscles of the urogenital diaphragm, the compressor 
urethrae and the urethrovaginal sphincter, start.29,85 Although they are continuous with the 
striated urethral sphincter fibres,89 they are not circular, but rather omega-shaped.96,97 The fibres 
of the compressor urethrae ultimately attach to connective tissue next to the perineal membrane 
bilaterally, near the inferior pubic rami. As its name suggests, the urethrovaginal sphincter 
surrounds both the urethra and the vagina.29,90 Contraction of these two muscles compresses the 
lumen of the urethra against the anterior vaginal wall.29 Small nerves running off the terminal 
branch of the pudendal nerve innervate the compressor urethrae and the urethrovaginal 
sphincter.96 
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2.1.2.2 Extrinsic mechanism 
Support for the urethra (Figure 2.3) is derived posteriorly and inferiorly from the anterior 
vaginal wall,29,30 the endopelvic fascia, the arcus tendinous fasciae pelvis (ATFP) and the pelvic 
floor muscles (PFMs).29,88,90 The endopelvic fascia is a thick, fibrous layer of connective tissue 
that surrounds the vagina and the ATFP laterally.29,90 This fascia contains collagen, a high 
concentration of elastin and, unlike other fascia within the body, it also contains smooth muscle 
fibres.93,98 Each ATFP attaches to the pubic bone ventrally and the ischial spine dorsally. They 
are tensile structures that suspend the anterior vaginal wall, and through it the urethra, from the 
pelvis,29,90 preventing both the vagina and the urethra from moving inferiorly and posteriorly.99 
 
Figure 2.3: Sagittal section of the components of the urethral support system.  
From: Delancey, J. O. L. and J. A. Ashton-Miller (2004). Pathophysiology of adult urinary incontinence. 
Gastroenterology 126, Supplement 1(0): S23-S32. (© Delancey 2005) 
 
The PFMs are striated muscles within the pelvis, made up of the pubovisceral, iliococcygeus 
(which together form the levator ani) and ischiococcygeus (coccygeus) muscles (Figure 2.4).93,100 
The pubovisceral muscles are comprised of puborectal and pubococcygeal components, and 
originate from both the left and right ventral pubic bones. Each pubovisceral muscle curves 
posteriorly and inferiorly past the urethra, vagina and anorectum to attach to its contralateral half 
behind the rectum and inserts into the anal sphincter complex and the anococcygeal raphé.93,100 
Together they form a U-shaped sling of muscle that maintains constant tone to keep the 
urogenital hiatus closed, relaxing only during micturition and defaecation.90,101 The central space 
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through which the anus, vagina and urethra pass is called the urogenital hiatus; it is supported 
ventrally by the pubic bones, laterally by the PFMs and dorsally by the perineal body and 
external anal sphincter.85,93  
 
Figure 2.4: Pelvic floor muscles in sagittal section of the pelvis.  
From: Raizada, V. and R. K. Mittal (2008). "Pelvic Floor Anatomy and Applied Physiology." Gastroenterology 
Clinics 37(3): 493-509. 
 
The iliococcygeus forms a flat sheet that runs from the pelvic sidewall to the midline, 
originating at the arcus tendinous levator ani (ATLA) bilaterally. The ATLA is a thickened 
portion of the fascia that overlies the medial aspect of the obturator internus (OI) muscle, 
originating on the posterior aspect of the pubis and inserting on the ischial spine.99,100 The ATLA 
suspend the pubococcygeus and puborectalis muscles anteriorly and they anchor the 
iliococcygeus to the pelvic sidewall;99 ensuring that the PFMs function independently of the OI, 
regardless of the state of OI contraction or relaxation.90 From the ATLA, the iliococcygeus 
traverses posteriorly, medially and obliquely downward, inserting on the coccyx and 
anococcygeal raphé, opposite its contralateral partner.100 The anterior fibres of the iliococcygeus 
run medially and caudally, while the posterior fibres are more horizontally-oriented, providing a 
shelf to support the pelvic organs.29,90,92,93,100 The ischiococcygeus muscle overlies the 
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sacrospinous ligament, originating from the pelvic surface of the ischial spine, and attaching to 
the lateral aspect of the coccyx and distal sacrum.100 
Innervation of the PFMs is highly variable. The perineal and inferior rectal branches of the 
pudendal nerve (S2 to S4),102,103 as well as direct sacral nerves from S3 through S5,88,102-105 have 
been most commonly reported. A variant of the inferior rectal nerve (S3 and/or S4) which is 
independent of the pudendal nerve has also been found to innervate the PFMs directly.102  
The PFMs are comprised primarily (70%) of type I (slow twitch) striated muscle fibres,90,101 
but they also contain smooth muscle fibres that increase in number medially and eventually split 
into their own layer of muscle.106 It is hypothesized that the smooth muscle fibres may be 
responsible for the resting electromyographic activity in the PFMs and that these fibres are likely 
responsible for the change in PFM tone in response to visceral weight and gradual changes in 
intra-abdominal pressure (IAP).104,106  
Although the PFMs are composed of three pairs of anatomically distinct muscles, there is no 
evidence to suggest that they can be activated independently, but rather that contraction produces 
a collective compound action that is the product of the various muscle fibre directions. 
Contraction of the pubococcygeus, iliococcygeus and ischiococcygeus results in flexion of the 
coccyx ventrocranially and elevation of the PFMs themselves, thus providing mechanical support 
for and lifting of the pelvic viscera in a cephalic direction.107-110 Contraction of the puborectalis 
results in a decrease in levator hiatus area and compression of the urethra,111 vagina and rectum 
in an anterior direction against the pubic bone.93,107 These closure and support functions of the 
PFMs also protect the connective tissue within the pelvis from stretching.29,85,92,99 
2.1.2.3 Physiology 
To maintain continence, urethral closure pressure must exceed bladder pressure, both at rest 
and with increases in IAP.90,112 In healthy women, the resting tone of the urethral smooth 
muscles and the striated sphincter complex, and the passive force from the vascular plexus, 
ensure that the urethral pressure is higher than the bladder pressure at rest.29,90 As the bladder 
fills, contraction of the PFMs is thought to assist with generating sufficient urethral closure 
pressure. With activities that increase IAP, such as coughing or lifting, both active and passive 
components contribute to enhancing urethral closure and maintaining continence.29,112-115 In 
healthy women, when IAP increases, the striated urethral sphincter contracts to close the 
proximal urethral lumen. PFM contraction stabilizes the bladder neck; limits the descent of the 
  13 
urethra, preventing it from being stretched open; and increases pressure within the distal portion 
of the urethra.114,116 The increasing IAP passively compresses the bladder neck and proximal 
urethra against the endopelvic fascia, the ATPF, the PFMs and the anterior vaginal wall.90,114-116 
Contraction of the PFMs also assists with this passive action by increasing the stiffness of the 
supportive layer by pretensioning the endopelvic fascia and vaginal wall tissues, providing a 
backstop against which the abdominal pressure compresses the urethra.90,98,116 Through these 
actions, the PFMs also protect the connective tissue from undue stress.  
In addition to luminal closure and pelvic organ support, the PFMs have been shown to be 
active with quiet breathing, and involved in the anticipatory postural adjustments associated with 
postural perturbations, such as arm movements, leg lifts and catching a weight.115-117 Recent 
evidence also indicates that the PFMs assist, not only with maintaining continence during forced 
expiration, such as a cough,118 but also in improving the efficacy of the expiratory effort.119 
Thus, it is clear that the PFMs play multiple roles in maintaining continence, improving postural 
stability and expiratory effort, and that injury to the PFMs may have multiple, overlapping 
consequences.  
2.2 Aetiology of SUI in Young, Nulliparous Women 
Stress urinary incontinence (SUI) seems to be produced by overlapping deficits in multiple 
components of the continence mechanism. Factors associated with SUI in young, nulliparous 
women include increased body mass index (BMI),32,34,35 smoking,11,35,42,43 chronic 
constipation,9,32,44 high impact physical activity,13-17,34,36-39 oral contraceptive use,40,41 sexual 
activity,12 and a history of urinary tract infections (UTIs).10,32 Familial traits, such as connective 
tissue composition, have also been suggested as potential factors.16,45-48 However, the evidence 
for most of the lifestyle factors is inconclusive, particularly in young women. There is stronger 
evidence for familial traits. Currently, the most robust models based on studies of twins suggest 
that SUI in young women is the result of equal parts genetic predisposition and environmental 
factors.49 
2.2.1 Lifestyle Risk Factors 
Body mass index has long been considered to be a risk factor in the development of SUI, but 
the current literature is unclear regarding this association.8,11,32,34,35,120-122 In a Swedish 
questionnaire-based study, the authors found no significant difference between the mean weight 
of the continent group (64.6 kg ± 0.5) and the incontinent group (65.8 kg ± 0.8);11 a finding 
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supported by another study of Australian university students, which reported that although the 
women with daily leakage were heavier than those without incontinence, the effect disappeared 
when adjusted for age.12 These findings are not supported by the Norwegian EPICONT study 
(6876 incontinent women and 21,060 controls), which reported that increasing body mass index 
was strongly associated with SUI, showing a clear dose-response relationship.35 In another 
Norwegian study, Bø et al. had mixed results relating body mass index to SUI.34 In their study 
comparing UI in elite athletes and healthy controls, no significant difference was reported in the 
prevalence of SUI in athletes of differing body mass indices. However, a higher prevalence of 
SUI was observed in controls with a body mass index of 25 or greater (p=0.001). These differing 
results between the athletes and controls may relate to a lower number of women with high BMI 
in the elite athlete group or that the damaging stress on the pelvic floors of the elite athletes is 
similar, regardless of BMI. Alternately, damage from constant loading may not have had time to 
develop in young women, thus showing no effect of BMI.  
Smoking has been suggested as a risk factor for SUI,8,11,35,42,43 with two plausible 
explanations: first, the chronic smokers’ cough, as smokers generate greater increases in bladder 
pressure when coughing than non-smokers,43 and second, smoking has been shown to interfere 
with collagen synthesis.11 A Swedish-based study of 487 women between the ages of 20 and 59 
reported that UI was more prevalent among smokers than non-smokers (OR: 1.78; 95% CI 1.12-
2.86).11 An initial analysis of the EPICONT study found that neither former nor current smoking 
increased the risk for SUI.35 However, when investigations included the number of cigarettes 
smoked, a dose-response relationship appeared, with a slightly increased and significant odds 
ratio for greater that 20 cigarettes per day (OR: 1.2; 95% CI 1.0-1.5). The authors also reported a 
weak dose-response relationship between UI and number of pack years for both former and 
current smokers. The association between smoking and severe UI was even stronger. However, 
data on young women with SUI and smoking is lacking. It is possible that no correlation would 
be found in this population, as there might not be enough time for injuries to the continence 
mechanism to develop, but further research is required to determine the effects of smoking on 
SUI in young women. 
Chronic constipation is another risk factor for SUI.9,32,44 A study from the mid-1980s reported 
that severely constipated women who had strained at stool for prolonged periods demonstrated 
damage to the pudendal nerve, potentially affecting urethral sphincter function.123 Another study 
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investigating bowel function compared 24 women with SUI and 27 controls (mean age: 52 years 
both groups).44 The authors found that significantly more women with SUI strained excessively 
during bowel movements as young adults (30%), compared to 4% of the controls (p=0.018). 
Despite the differences in straining as young adults, both groups demonstrated similar rates (9% 
vs. 8%) of infrequent bowel movements (less than twice a week), suggesting that straining, 
rather than frequency of bowel movements might be associated with SUI. How constipation 
affects young women is less clear and further research in this area is required to clarify any 
correlations. 
High impact physical activity has also been linked to increased prevalence of SUI.13-17,34,36-39 
Indeed, surveys of physically active, young women have found higher prevalence rates for SUI: 
41 to 49% in college and elite athletes13,34 and 19 to 31% of women in the armed forces,14-17 
compared to prevalence rates of 3.7% to 14% in the overall population of young women.4,7-12 
One study investigated 291 elite athletes and dancers between the ages of 14 and 51 years, 
finding that 51.9% of the respondents experienced urine loss during their sport (43.0%) or in 
daily life situations (42.2%).39 In a comparison between Norwegian elite athletes (n=572) and 
age-matched controls (n=574) between the ages of 15 and 39 years, the overall prevalence of 
SUI was not significantly different (41% versus 39%, p-value not reported).34 However, leakage 
during physical activity was significantly more prevalent among the athletes (29% versus 22%; 
p=0.009). In both groups, 5% reported SUI to be a moderate to severe problem. In spite of this 
high prevalence, the aetiology of SUI in this physically active population remains to be 
elucidated. It has been suggested that high ground reaction forces and increases in intra-
abdominal pressure provoked by the activity may unmask SUI.13,21,124 It is also possible that the 
connective tissues and the PFMs can become over-stretched by intense activity over time, 
resulting in SUI.36 Furthermore, maximum voluntary contraction of the PFMs, as measured by 
vaginal pressure, has been shown to decrease after 90 minutes of strenuous physical activity, 
indicating fatigue, possibly increasing the risk of SUI.125 
The literature pertaining to the association between oral contraceptive use and urinary 
incontinence is contradictory, with some studies finding positive associations between oral 
contraceptive use and UI,40 some finding negative associations10,41 and still others finding no 
association at all.11 The Nurses’ Health Study II of pre-menopausal women, for example, 
reported that the use of oral contraceptive pills was significantly associated with UI (OR 1.27; 
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95% CI 1.01-1.59), with the odds of UI increasing significantly with increasing duration of pill 
use (p=0.03 for trend).40 Oral contraceptive use was associated with SUI (OR 5.40; 95% CI 1.66-
17.50) in nulliparous women despite no significant association in the overall study population 
(OR 1.04; 95% CI 0.78-1.40). On the other hand, in a study based on the Swedish Twin Registry, 
oral contraceptive use was found to be inversely correlated with SUI (OR 0.57; 95% CI 0.41-
0.79).41 In order to address the potential covariance of oral contraceptive use and sexual activity, 
a group of Australian researchers investigating female university students discovered that those 
who were sexually active and not using a oral contraceptives reported higher rates of UI (21.5%; 
95% CI: 16.7-27.3%) than did those who were never sexually active and not using an oral 
contraceptive (10.1%; 95% CI: 7.0-14.4%) or sexually active and using an oral contraceptive 
(9.7%; 95% CI: 6.4-14.3%).12 The group with no reported oral contraceptive use, but who were 
sexually active exhibited a higher odds ratio of UI than in the group who were never sexually 
active (OR: 2.17; 95% CI 1.24-3.80; p=0.007), suggesting that UI may be related in some 
capacity to sexual activity. The role of oral contraceptives in SUI and how they may co-vary 
with other risk factors has yet to be elucidated.  
Urinary tract infections are also purported to be associated with UI, particularly in the older 
population.32 A questionnaire-based study from a community in Sweden investigated this 
association and found that the number of women who reported urinary tract infections was twice 
as frequent in the UI cohort, compared to the cohort without UI (p<0.01), and occurred most 
frequently in the youngest group of women (18-30 years);10 although another study disputed this 
finding.12 The mechanisms behind how UTIs affect UI are unclear, particularly in the young 
population. It is possible that the young women in the Swedish study who were reporting UI 
were experiencing it while they had a UTI. Alternately, if a young woman has some structural 
deficiencies (muscle and/or connective tissue), which predispose her to UI, those structural 
changes may also put her at a higher risk for UTIs. Additional investigations are required to 
further elucidate these correlations. 
2.2.2 Familial Traits  
Population-based studies, including twin studies, have permitted the analysis of genetic versus 
environmental factors related to UI.33,49,126,127 Overall, studies have found that 30 to 50% of UI is 
related to heritability. A large Swedish study of 8452 female twins reported that genetic effects 
accounted for approximately 41% of the variation in UI, the environmental influence on UI was 
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of the same magnitude (40%), supporting the idea that the aetiology of SUI is multi-faceted.49 
An Australian twin and sister study of young, nulligravid women, looked at bladder neck descent 
on Valsalva, a marker for SUI, and found that approximately 50% of urethral and bladder 
mobility was related to genetic factors.128 A Norwegian study investigated the relative risk of UI 
amongst mothers and daughters and between sisters.127 It found that daughters of mothers with 
any type of UI were 1.3 times more likely to have incontinence, and that female siblings were 1.6 
times more likely to experience UI if their older sisters experienced leakage. An American group 
compared UI within sister pairs, in which one was parous and the other nulliparous.33 No 
significant difference in the prevalence of UI was found between the groups (p=0.782), and 
between the sister pairs the concordance of continence status was 63% (χ2=9.5715, p=0.002), 
suggesting that familial factors play a greater role than parity in the development of UI.  
2.2.2.1 Connective tissue 
 The extracellular matrix of connective tissue is comprised of collagen and elastin fibres, 
glycoproteins and proteoglycans, with collagen fibres being the major component.129,130 Collagen 
contributes strength to connective tissue, while elastin gives it elasticity and the ability to 
recoil.131 The connective tissue of the pelvic floor plays an important role in the continence 
mechanism. Without healthy, intact connective tissue, the tensile strength of the fascia and 
ligaments may be reduced, impairing the relationship between the fascia and muscles, thereby 
weakening the muscular support system.129,132,133 
Collagen. In the early 1990s, researchers discovered that skin fibroblasts produce and secrete 
30% less collagen in women with SUI compared to continent women.48 When the focus shifted 
to the continence mechanism, it was found that there was a significant reduction in collagen 
content in the endopelvic fascia129 and in the periurethral musculature in women with SUI 
compared to those without.129,130 Collagen fibres in the paraurethral connective tissue also 
demonstrated increased diameter and cross-linking, potentially resulting in stiffer tissue, making 
urethral closure more difficult.47 Another study also found that the fibril orientation was less 
organized and that the fibrils were frequently collapsed or broken.130 Keane and colleagues134 
compared collagen in the periurethral tissue of premenopausal, nulliparous women, with and 
without SUI. In the women with SUI, collagen content (29% versus 39.7%, p<0.0001), type I to 
type III collagen ratio (65:35 versus 71:29, p=0.008), and cross-linking were all significantly 
reduced. Type I collagen is regarded as the supportive collagen, whereas type III collagen is 
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found where less rigidity is required. Thus, a decrease in total collagen content, the amount of 
type I relative to type III collagen and cross-linking would all result in tissue that is less 
supportive and mechanically weaker.134 It is less clear whether there is any change in collagen 
metabolism, with various studies finding no difference in collagen production,135 reduced 
collagen turnover,136 and increased collagenolysis in the periurethral tissue of women with SUI 
compared to those without.137  
The discrepancies in the research suggest the possibility that different collagen remodelling 
pathways may be activated, depending on injury type and severity, mechanical load, genetic and 
lifestyle factors.45 Chen and Yeh45 proposed a model to explain SUI development: pelvic tissue 
in women with a genetic predisposition to SUI exhibits chronic abnormal collagen remodelling, 
which is modulated by cyclic changes in ovarian hormones, and exacerbated by trauma and 
mechanical loading of the pelvic floor. They postulated that this abnormal remodelling 
ultimately disrupts normal tissue architecture and its mechanical properties, resulting in SUI. 
However, it is also possible that SUI collagen pathways may be implicated in women without a 
genetic predisposition, as collagen structure is dependent on loading, and loading is altered 
following injury.138,139 
Elastin. While much of the research on the endopelvic fascia has focused on collagen 
morphology and metabolism, elastin fibres have also been implicated with SUI. Women with 
SUI have been shown to demonstrate an irregular and fragmented elastin distribution within the 
periurethral tissue,140 and an increase in elastase, which is involved elastin degradation.131 As 
elastin imparts extensibility and the ability to recoil to a tissue, changes to these fibres may 
prevent efficient closure of the urethra. Taken together, it is clear that composition and 
metabolism of both of the major components of endopelvic connective tissue: collagen and 
elastin, are altered in women with SUI, resulting in stiffer, weaker, less supportive tissues and 
increased risk of SUI. 
2.2.2.2 Muscle changes  
Muscular changes in the striated urethral sphincter and PFMs have also been implicated in 
SUI. A study comparing striated urethral sphincter electromyography (EMG) in 38 women with 
SUI to 10 continent controls, found that 73% of the symptomatic women demonstrated a lower 
amplitude, shorter duration EMG pattern consistent with intrinsic muscle damage rather than 
denervation.141 Those with the altered pattern also demonstrated functional changes, such as 
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significantly lower Valsalva leak point pressure (p=0.002) and more urine loss during pad testing 
(p=0.0101), compared with those with no EMG changes. The authors were not able to comment 
on the type of muscle damage, but another study found muscle cell apoptosis in the striated 
urethral sphincter, with concomitant replacement by fat cells and connective tissue, in those over 
20 years of age.142 Intraurethral ultrasound studies have demonstrated decreased thickness of the 
striated urethral sphincter in women with SUI, potentially supporting the findings of muscular 
damage in the study above.143  
Similar findings have been reported for the PFMs. Sixteen women (8 women with and 
without SUI) underwent MRI evaluation of their PFMs with concomitant surface PFM EMG 
studies.108 The results revealed that the pubococcygeus was not as thick in those with SUI 
(p=0.04), and those women also had lower EMG amplitudes (p=0.03). PFM thickness correlated 
with the EMG findings (r=0.49-0.53). In a study investigating the relationship between bladder 
pressure during a cough and PFM surface EMG activity, the investigators found that the EMG 
activity for a given bladder pressure was lower for those with SUI than for the control group.112 
In addition, the effect of continence status was different according to the bladder volume (0, 200 
and 400 ml; p=0.0001), with the PFM EMG for a given bladder pressure being lower for those 
with SUI than for the control group, except in the case of the 400 ml filling. This lack of 
demonstrable difference between the two groups at 400 ml may be because there is increased 
voluntary PFM contraction as the desire to void increases. In addition, the authors point out that 
the control group was not healthy, but was rather a group of continent women with overactive 
bladder syndrome. 
2.2.2.3 Functional deficits 
Muscle coordination, timing and strength. Prior to a sudden increase in IAP in continent 
women, urethral pressure rises,114,115 and the PFMs contract.133 The increase in urethral pressure 
occurs 120-200 msec prior to the increase in bladder pressure and is indicative of an intact 
continence mechanism; this pre-activation is not seen in women with SUI.98,115,144-147 Pre-
contraction of the PFMs has also been reported in continent women prior to postural 
perturbations.98,116 Compared to continent controls, PFM surface EMG activity in women with 
SUI was delayed (p=0.002) until after a rapid arm movement had begun, rather than acting in an 
anticipatory fashion.116 During shoulder flexion in the continent women, PFM EMG increased 
18.1 (SD 33) ms before the anterior deltoid, whereas PFM EMG increased 5.3 (SD 36) ms after 
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deltoid initiation in the group with SUI. The pattern was similar with shoulder extension: 26.9 
ms (49) prior to posterior deltoid activation for the controls versus 15.4 (43) ms after activation 
for the women with SUI. Other studies have demonstrated the disruption of this feedforward 
mechanism in women with SUI when performing leg movements,117 catching a weight,115 and 
coughing.98,118,146  
A study by Thompson et al.148 investigated abdominal and PFM surface EMG activation 
patterns in women with and without SUI. With a PFM contraction, the symptomatic group 
showed lower levels of PFM activation (p<0.001) and higher levels of abdominal and chest wall 
muscle activation (p<0.01), when compared to the asymptomatic group. Furthermore, the 
incontinent women had significantly weaker PFMs on manual muscle testing and appeared to 
have difficulty isolating the PFMs; rather they globally activated all of the muscles in the region 
when asked to perform a PFM contraction. The authors proposed that muscle substitution might 
be the cause of this altered strategy: when a muscle is weakened, there is a shift of motor 
activity, enabling synergistic muscles to perform the task. Alternately, differences in cortical 
control, awareness of PFM contraction and muscle coordination in symptomatic women could 
also be at fault. Another group investigated the influence of abdominal muscle activation on the 
ability to contract the PFMs in continent women.149 They found that bladder neck elevation 
during a PFM contraction (indicating a proper contraction) was influenced by IAP. When the 
abdominal muscles (obturator internus, obturator externus and rectus abdominis) contracted, the 
PFMs were not able to overcome the increase in IAP and the bladder neck was not elevated. 
Combined, these studies suggest that if women are presenting with abnormal muscle activation 
patterns, or if their abdominal muscles are dominant, then the PFMs may not be able to 
appropriately respond to an increase in IAP and prevent SUI. 
Research findings related to PFM strength in women with SUI differ widely in the literature, 
varying from decreased, no difference, to increased strength.115,121,148,150-152 Chamochumbi et 
al.150 investigated PFM strength in 16 continent and 16 women with SUI, with the use of a 
dynamometer. They found that the anteroposterior active strength for the control group was 
significantly greater than that of the women with SUI (0.3±0.2N versus 0.1±0.1N, p<0.01). 
However, the lateral strength showed no difference (0.43±0.1N versus 0.40±0.1N, p=0.2). In 
another dynamometric study, a Canadian group also demonstrated that women with SUI have 
weaker PFMs than their continent counterparts, as measured by absolute endurance, maximal 
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rate of force development and number of contractions performed (p<0.05).151 Similarly, in a 
surface PFM EMG study, continent women demonstrated significantly higher PFM EMG 
amplitudes than the women with SUI (p<0.001).121 Verelst and Leivseth152 also compared PFM 
dynamometric measurements between women with and without SUI, finding no significant 
differences between the two (p=0.153). Contrary to predictions of the authors, another surface 
PFM EMG study by Smith et al.115 found EMG amplitudes in women with SUI are greater than 
in continent women prior to (p=0.011) and during (p=0.034) loading tasks. These findings were 
also associated with increased EMG activity in the obliquus externus abdominis, which would 
increase IAP and intravesical pressure, thus increasing the demand on the PFMs and passive 
structures.115,149 The increase in PFM activity may also represent a compensatory mechanism to 
decrease urinary symptoms.98,115 
Madill and colleagues121 compared maximum surface PFM and abdominal muscle EMG and 
intravaginal pressure amplitudes among women with mild and severe SUI, and a continent 
control group. Continent women demonstrated significantly higher PFM EMG amplitudes than 
both of the groups with SUI (p<0.001), but interestingly, the three groups demonstrated similar 
vaginal and intra-abdominal pressure measurements (p=0.21 and p=0.48, respectively). The 
abdominal muscles were also found to be more active prior to the rise in vaginal pressure in the 
women with SUI compared to their continent counterparts (p<0.001). These findings suggest a 
multi-faceted causal mechanism in women with SUI. Pelvic floor muscle weakness in women 
with SUI is supported by the lower PFM EMG amplitudes, and altered fascial support is 
indicated by the earlier activity in the abdominal muscles relative to the vaginal pressure rise, 
suggesting the initial force produced by the abdominal muscles was used to take up the slack of 
pelvis support structures. Altered motor control is implied by the finding that intravaginal 
pressure was the same in all three groups, even though women with SUI exhibited lower 
maximum PFM and abdominal EMG amplitudes. Those women likely used different muscle 
activation patterns to generate this pressure.  
When they investigated coughing, Madill et al.147 found that PFM EMG and vaginal pressure 
increases were similar between women with and without SUI, suggesting that muscle weakness, 
at least during reflex contractions, may not be a factor in SUI. They found differences in the 
timing of muscle activation relative to vaginal pressure, with women with SUI having a slower 
PFM response. They also found that the women with SUI had higher levels of PFM and 
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abdominal muscle activation at the point when vaginal pressure began to rise. Again, their 
findings support the idea that SUI may more likely be due to a combination of altered fascial 
support and motor control. 
Neuromuscular fatigue. As any skeletal muscle can be affected by neuromuscular fatigue, 
researchers have also investigated fatigue in the PFMs and the striated urethral sphincter.113,125,153 
Twelve nulliparous women with SUI participated in a cross-over study in which they underwent 
90-minutes of interval training and then rested for 90 minutes, or did the activities in the reverse 
order.125 The mean maximal voluntary contraction of the PFMs was decreased by 20% after the 
strenuous activity (p<0.01), suggesting the development of muscle fatigue. These findings are 
supported by studies using pad testing that have demonstrated greater leakage in the second 
test.75,154 However, in a fatigue task which involved contracting and holding the PFMs for as 
long as possible, no demonstrable decrease was found in PFM force generation was found in 
volunteers with and without SUI.153  
Another group induced fatigue by having volunteers with and without SUI perform seven 
hard coughs.113 Maximal urethral closure pressure decreased by 14% in those with SUI, and only 
5% in the control group (p=0.0011). The same authors investigated the effects of PFM fatigue 
and increasing cough efforts on the modulation of a pelvic contraction, based on surface EMG 
from the external anal sphincter.146 They reported that the strength of the external anal sphincter 
contraction was modulated to the strength of the cough effort and that performing ten successive 
strong coughs had no effect on modulation in those with or without SUI. However, ten PFM 
contractions followed by a maximal PFM contraction sustained until exhaustion significantly 
decreased the modulation of PFM contraction during increasing cough efforts (p=0.043) in those 
with SUI only. In addition, the timing of the PFM pre-contraction was delayed in the women 
with incontinence, and the more the pre-activation was delayed, the more the modulation of the 
pelvic contraction was decreased with increasing cough efforts. The results suggest that the 
capacity to modulate the PFM response to meet the demands of increased IAP may be affected 
by fatiguing PFM exercises in women with SUI. 
Lumbo-pelvic position. Lumbo-pelvic position has been linked to changes in continence 
status. In a study by Sapsford et al.,155 17 women with and without SUI underwent surface PFM 
EMG with concomitant surface abdominal EMG. As women moved from slumped to upright 
sitting, there was a significant increase in resting PFM EMG amplitudes (p<0.001). However, 
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women with SUI had lower PFM EMG in both positions compared to their continent 
counterparts (p<0.05). Furthermore, women with SUI had significantly less lumbar lordosis than 
the asymptomatic controls (p=0.04). This last finding is consistent with some previous research 
into spinal curvature and pelvic organ prolapse.120,156,157 In one study, a positive correlation was 
found between thoracic kyphosis and prolapse; increased kyphosis was associated with higher 
IAP.156 Following on the heels of that study, Mattox et al.120 chose to investigate lumbar lordosis 
in relation to pelvic organ prolapse in 363 women. In the women who were diagnosed with an 
abnormal spine, 91% had a history of pelvic organ prolapse. The most prevalent spinal change 
was a loss of lumbar lordosis (75%), suggesting that a loss of lumbar curvature may direct more 
forces onto the pelvic floor and may be a significant factor in the development of pelvic organ 
prolapse. Nguyen et al.157 also investigated the relationship between uterovaginal prolapse and 
the degree of lumbar lordosis and the angle of the pelvic inlet in women with and without 
prolapse. Women with prolapse had significantly less lumbar curve (p<0.003) and a significantly 
larger angle of the pelvic inlet (p<0.001) compared to those in the control group. Whether a 
normal lumbo-pelvic curvature directs the intra-abdominal forces anteriorly to the anterior 
abdominal wall and pubic symphysis, thereby protecting the pelvic floor;156 that flattening the 
lumbar curve brings the pubic symphysis anterior and superior, thereby making the pelvic floor 
the sole recipient of the downward pressure;157 or simply that the PFM activity is increased in 
this position, thereby supporting the pelvic organs,155 has yet to be determined. 
The evidence strongly suggests that SUI has a complicated, multifactorial aetiology. While 
the evidence from familial studies suggest that 30-50% of SUI is related to heritability,33,49,126,127 
how the environmental and familial factors interact is much less clear. 
2.3 Measurement 
Objective assessment of urine leakage is required to determine the severity of a woman’s 
symptoms and to document changes in her symptoms following an intervention. Several testing 
procedures have been developed to assess various aspects of UI: patient-reported outcome 
questionnaires (PROs), bladder (urinary) diaries, urodynamic testing, cough stress (paper towel) 
tests, and pad tests.  
2.3.1 Patient-Reported Outcome (PRO) Questionnaires 
There are a number of UI specific PRO tools that have been developed to assess a variety of 
concepts: such as health-related quality of life, symptom severity, symptom bother and patient 
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satisfaction with treatment. These PROs allow clinicians and researchers to collect standardised 
data, allowing for quantification and comparison of subjective information. They permit a review 
of symptom impact and treatment benefit from the individual’s perspective, as clinical 
assessment tends to focus on issues of lesser importance to patients and to underestimate the 
degree of bother experienced by the patient.69 However, it has been reported that a person’s 
perception of continence status and reporting of leakage episodes is modulated by differences in 
personality characteristics.158 As such, even though the use of PROs allows the investigator to 
quantify and compare subjective information, the results do not correlate very well with more 
objective findings.54 
Recently, the International Consultation on Incontinence, supported by the World Health 
Organization, initiated the development of questionnaires for the purpose of assessing different 
aspects of UI – the International Consultation on Incontinence Modular Questionnaire (ICIQ).159 
All of the modules, which include urinary symptoms and quality of life tools, have undergone 
rigourous psychometric testing and have published evidence regarding the reliability and 
responsiveness of the instrument. In addition, the fourth International Consultation on 
Incontinence has evaluated, rated and recommended multiple UI-specific PROs.69 Currently no 
consensus exists on the most effective scales to use for assessing UI, not because the PROs lack 
scientific validity, but rather because consensus is lacking on the most important concepts to 
measure. The Incontinence Impact Questionnaire (IIQ) and the Urogenital Distress Inventory 
(UDI) are two commonly used scales to assess health-related quality of life and symptom bother, 
respectively, in women with UI.53 The IIQ was designed to assess the impact of UI on the 
activities and emotions of women. The UDI, developed to complement the IIQ, was designed to 
assess the degree to which UI symptoms are bothersome.160 Both of these PROs have been 
validated in women with a diagnosis of UI confirmed with urodynamic testing,160,161 but have not 
been found to be valid in woman without a urodynamic diagnosis of UI, when compared to the 
one-hour pad test.52 Women in the community who have not undergone urodynamic testing may 
have less severe UI and their symptoms may differ in pathophysiology, compared to those with a 
urodynamic diagnosis.52 In addition, urodynamic studies may have false-negative results, as 
some studies have found that symptoms are not a good predictor of urodynamic SUI.162,163 
Huang et al.54 performed a retrospective analysis of 707 women (mean age of 49.8 years) that 
sought to explore the relationships among quality of life measures (UDI-6 and IIQ-7), symptom 
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severity (1-hour pad test and the Ingelman-Sundberg severity scale), urethral support (bladder 
neck angle at rest and with straining, bladder neck rotational angle and funneling) and urethral 
sphincter function (Valsalva leak point pressure and maximum urethral closure pressure). The 
scores of both PROs and symptom severity were positively correlated (r=0.15–0.40, all p<0.05), 
but the scores on the PROs were not correlated with items related to urethral support or urethral 
sphincter function. However, item 3 of the UDI-6 (related to SUI) was significantly correlated 
with bladder neck funneling (r=0.14, p<0.05) and maximum urethral closure pressure (r=-0.15, 
p<0.05). The authors argue that the weak correlations found in the study suggest multifactorial 
mechanisms behind the pathophysiology of SUI and the complex nature of the subjective 
perception of SUI. They propose that quality of life and pathophysiological measures play 
complementary but independent roles in the assessment of SUI. 
PROs are valuable tools to assess the subjective experience of the woman with SUI, and they 
permit the clinician and researcher to quantify and compare that subjective information. 
However, they do not correlate well with pathophysiological measures and cannot quantify the 
amount of urine leakage. Including PROs in research and clinical practice is important, but each 
PRO needs to be selected based on the needs of the investigator, as well as the purpose for which 
the PRO was developed. 
2.3.2 Bladder (Urinary) Diaries 
A bladder diary, completed by the patient, is a record of her voiding pattern during her normal 
daily activities. The information in the diary can include the following: time, amount and type of 
fluid intake; volume and frequency of urine output; time, provoking activity and severity of UI 
episodes; degree and provocation of urgency; and pad usage. The goals of the diary are three-
fold: 1: to provide the patient with insight into her bladder behaviour; 2: to provide the clinician 
or researcher with a number of measurements, including UI frequency and approximate quantity 
of urine loss, and 3: to offer the clinician or researcher insight into the individual’s behaviours 
and habits associated with voiding. In addition, diaries can be used to monitor symptoms and 
quantify response to treatment.56  
The diary can be completed over a 24-hour period, or can be as long as seven days. 
Investigations in older women with SUI have found that it is necessary to complete a seven-day 
diary to reach internal consistency as determined by Cronbach’s alpha measure (r=0.90), while 
only five days are necessary in older women with urge type UI.164 No similar data exist for 
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younger women. However, it has been shown that compliance decreases with longer diary 
duration56, with one study reporting a completion rate of 90.7% compared to 50% for three- and 
seven-day diaries, respectively.165 A study that evaluated the reproducibility of a seven-day 
voiding diary in women with SUI found that there was a high correlation between the first three 
days and the last four days in the number of incontinence episodes (r=0.887) and number of daily 
voids (r=0.908), thereby suggesting that a three day chart would be adequate for these 
parameters.166  
As with other PROs, bladder diaries are self-reported and therefore have the potential to 
introduce recall bias. Some argue that because subjective history correlates well with a bladder 
diary in number of UI episodes (r=0.63) and pad use (r=0.81), a good history-taking might be 
sufficient.55 While filling out the diary, a woman might alter her voiding habits to minimize her 
trips to the bathroom, decrease her caffeine consumption and/or change her fluid intake to what 
she perceives to be the “right” amount, skewing the results. However, if completed correctly, 
including filling out the diary as the events occur, diaries provide real-time documentation of 
urinary function, reducing recall bias, thereby confirming or disputing clinical history.56  
A recent literature review found that, while much of the literature on UI describes the use of 
bladder diaries, there are no studies showing evidence of content validity nor of psychometric 
testing.56 A new urinary diary for the adult population is being developed and tested; this may 
result in a tool that is psychometrically sound.167 
In summary, bladder diaries are useful to offer the woman with UI and the investigator with 
numerous, valuable insights into bladder habits. However, some issues related to compliance 
have been reported, and as it is a self-reported measure, there are concerns regarding recall bias. 
In addition, some women alter their habits when filling out the diary thereby skewing the results. 
2.3.3. Urodynamic Testing 
Urodynamic testing is an invasive functional study of the lower urinary tract, requiring the 
insertion of catheters into the urethra, bladder and rectum.50,57 Urodynamic testing includes a 
battery of different tests for diagnosing various lower urinary tract disorders, including SUI. 
“Urodynamic” or “genuine SUI” is diagnosed when involuntary urine leakage is observed with 
an increase in intra-abdominal pressure during the filling phase of the study, in the absence of 
detrusor contraction.57 Two other tests are also used in the diagnosis of SUI. The urethral 
pressure profile is assessed by continuously recording pressure while gradually withdrawing a 
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fluid-infused catheter from the urethra; it represents an idealized concept of the ability of the 
urethra to prevent leakage.50,57 Abdominal leak point pressure is a measure of the urethra’s 
ability to act as a valve to contain the urine within the bladder during coughing or Valsalva;50 it 
is determined by recording the abdominal pressure at the moment when urine loss is observed 
from the external urethral meatus.63  
Urodynamic testing has been considered for many years to be the cornerstone of lower 
urinary tract dysfunction assessment. However, new studies are calling this position into 
question.62,64-66,168,169 A recent systematic review by Weber64 concluded that some commonly 
evaluated urodynamic parameters, such as static urethral pressure profilometry or cough profile 
parameters are not standardised or reproducible and, therefore, are not able to contribute to the 
differential diagnosis in women with SUI symptoms. Poor reproducibility is due to large 
variations within and between patients, because of both biological variation and variation within 
testing procedures.57,64 In addition, Weber64 reported that maximum urethral closure pressure 
values in women with and without SUI overlapped so greatly it was impossible to select a cut-off 
that differentiates continence from incontinence. As well, this wide overlap would also make it 
impossible to determine minimally important changes. 
Many believe a low leak point pressure is diagnostic of intrinsic sphincter deficiency, thus 
defining the mechanism of SUI and predicting that surgical treatment will more likely fail.62,63 
However, leak point pressure measurements have not yet been standardised for testing position 
(supine, semi-recumbent, sitting, standing or standing with foot on stool), nor for the Valsalva or 
cough effort.168 Furthermore, it has been suggested that leak point pressure is more likely to 
measure to symptom severity than to define the underlying mechanism of SUI.62 However, a 
more recent study found no correlation between leak point pressure and incontinence severity as 
measured by either the Sandvik Incontinence Severity Index, the number of pads used, or the 
number of incontinence episodes.168 In addition, no correlation was found between leak point 
pressure and quality of life measures (UDI-6, IIQ-7, Prolapse and Incontinence Sexual Function 
Questionnaire short form-12, and Short Form-12, a generic measure of health-related quality of 
life). Taken together, these findings seriously question the utility of the leak point pressure as 
either a diagnostic test, or as a measure of symptom severity. 
In summary, urodynamic testing for SUI is not standardised or reproducible, and is not 
accurate enough to detect minimally important changes. In addition, the diagnostic equipment for 
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these studies is expensive and requires specialized personnel. Furthermore, while urine loss can 
be visualized with urodynamic testing, that leakage cannot be quantified. 
2.3.4 Cough Stress (Paper Towel) Tests 
A cough stress test is a simple test to diagnose SUI: the woman coughs forcefully with a full 
bladder, while the investigator or clinician watches for urine leakage from the urethra. It can be 
performed in supine or standing.58-60 The stress test uses a yes/no scoring system, in that urine 
loss is either observed or not. This method of scoring does not allow for quantification of urine 
loss, offering no way to differentiate between minor and severe incontinence, nor for detecting 
minimally important changes.  
Holding a paper towel to the perineum while the participant coughs and then calculating the 
size of the wet area on the towel (paper towel test) is a modification of the original test that 
allows the urine loss to be quantified.59 In a study investigating within- and across-visit test-
retest differences, the paper towel test was repeatable within visits (visit 1:p=0.18 and visit 2: 
p=0.59) and between visits (p=0.87). The paper towel test has been recommended for small 
amounts of urine loss (0-6 ml) because of the absorbency of the towel; for volumes greater than 
6 ml, it has been suggested that a pad should be used instead. 
The advantages of both of these tests are the immediate availability of the results and their 
simplicity, but the validity of the tests may be limited by the participant’s effort and bladder 
volume. Varying the testing position affects the results, as coughing provokes more urine 
leakage in standing compared to sitting or supine,170 likely due to significantly increased bladder 
pressures in standing,171 and the improved effectiveness of the cough in upright positions, due to 
the more advantageous position of the diaphragm.172 However, it has been noted that it is 
challenging for the practitioner to observe urine loss in standing;63 as well, testing in standing 
can be more time-consuming and difficult to perform.173 With the use of the paper towel test 
though, the difficulties in observing the urine loss are overcome.  
An investigation into the association between self-reported SUI (questionnaire) and the paper 
towel test was insignificant (r=0.12 to 0.27).67 The questionnaire overestimated the volume of 
urine lost in 83% of the cases. This finding suggests that either the paper towel test was 
insufficiently provocative to elicit the volume of urine loss that the individuals typically 
experience, and/or that individuals’ subjective assessment of “some” or “a lot” of urine leakage 
was smaller than the researchers’. The results of this study are consistent with an older study that 
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found the cough stress test was only positive in 64% of women with SUI, reflecting a notable 
number of false-negative findings.174  
In a study comparing the cough stress test to a 24-hour pad test in 55 women, the stress test 
was found to be more in agreement with urodynamic results (89% of women, kappa correlation 
coefficient =0.51) as compared to the pad test (60% of women, kappa correlation coefficient 
=0.08).68 Using the urodynamic results as a reference, the cough stress test had 90% sensitivity 
and 80% specificity, while the pad test had 60% sensitivity and 60% specificity. However, one 
would expect to see strong correlations, as the cough stress test used some of the same 
procedures as the urodynamic testing, including retrograde bladder filling. The investigators 
noted that 42% of the participants preferred the pad test compared to 29% favouring the cough 
stress test, primarily because the pad test was more comfortable and less embarrassing to 
perform. Furthermore, as previously discussed, there are inherent challenges in using 
urodynamic testing as a reference, given that the tests have not been shown to be reliable or 
specific. 
Cough stress tests assess for urine loss associated with SUI, which can be quantified with the 
modified paper towel test. The modified paper towel test is repeatable up to 6 ml of urine loss. 
However, some women find these tests embarrassing to perform. 
2.3.5 Pad Testing 
The objective of pad testing is to quantify the volume of urine lost by weighing an absorbent 
pad before and after some type of leakage provocation.69 Pad weighing was first described in 
1971 by James et al.,175 but it was not until 1981 that a standard set of activities was applied to 
the testing.176 It is inexpensive, non-invasive and easy to administer, and both the World Health 
Organization and the International Continence Society (ICS) recommend using pad testing as a 
method to detect and quantify urine loss.51 There are two kinds of pad tests: home-based (e.g. 12, 
24 and 48-hour tests) and office-based (e.g. short, one-hour and two-hour tests),51 with the type 
of test chosen depending on the goals.  
Home-based tests were developed to measure urine loss during a person’s typical daily 
activities. These tests are not intended to be provocative, but rather to determine the typical 
severity of leakage experienced by a woman on a daily basis. As such, these longer tests are not 
very structured, do not differentiate between stress and other types of UI, and they are difficult to 
reproduce. While the validity of a home-based test has been confirmed,177 clinical reports 
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indicate that patients who expect to experience considerable incontinence may compensate for 
this by voiding more frequently and/or drinking less, thus weakening the validity of the pad 
test.76,174 A pad weight gain of greater than 4.4 grams is considered positive for a 24-hour test, 
allowing for weight increases from perspiration and vaginal discharge.178 
Office-based tests (up to 2 hours in duration) were developed to overcome the difficulties of 
the longer tests. They involve the performance of a structured set of activities developed to elicit 
leakage. Some of these tests include manoeuvres to induce urge UI, and others are strictly 
exercise-based, to elicit SUI only. The benefits of the short pad test include: they are quick and 
easy to perform, they provide immediate results, and compliance of the participant can be 
directly monitored.80,178-180 A pad weight gain of greater than 1.4 grams is considered positive for 
a 1-hour test.178  
Home-based pad tests may be more representative of a woman’s daily urine leakage, as the 
participant undergoes her activities of daily living, but the tests are not able to differentiate 
between urge UI and SUI. In addition, some have voiced concerns over fluid loss secondary to 
evaporation prior to weighing the pad,179,181 and others have reported decreased compliance in 
returning the pad for weighing.74,180 On the other hand, office-based pad tests use a standard 
bladder volume and activity protocol, and they permit the investigator to structure the test so that 
it only provokes SUI. Since the exercises are standardised and are designed to provoke urine 
leakage, the shorter tests are more reproducible.70  
Since the first pad test protocol was published in 1981,176 there has been much debate in the 
literature as to whether pad testing has merit and if so, what the protocol should include. It 
became apparent quite rapidly, for example, that bladder volume should be standardised, as urine 
leakage was observed to increase with urine load.72 Many investigators suggested filling the 
bladder to a certain percentage of cystometric capacity (e.g. 50, 75 or 100%) or standardised 
amount (e.g. 250, 300 or 500 ml),71,73-75,77,151,154,182,183 while others argued for fluid loading with 
a standardised amount (500 or 1000 ml) and type of drink (sodium-free or orange juice).78-
80,174,184 A study comparing three different short pad tests with varying bladder volumes 
(unknown bladder volume, 250ml of infused saline, and after drinking 500ml water with a one-
hour wait), found that none of the tests were significantly correlated with each other. However, 
the test in which the participants drank water an hour prior had the fewest false negatives (6%) 
compared to saline infusion (9%) and unknown capacity (21%).185  
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For the tests that involved fluid loading, the timing of the exercise portion of the protocol after 
drinking became a topic of discussion. In order to ascertain when to start a pad test after fluid 
loading, Haylen et al.186 assessed baseline bladder filling rate in 20 parous women (mean age 
48.9 years; range: 31-77). The women were then catheterised and asked to drink one litre of fluid 
(usually fruit juice) as quickly as possible. The mean time (SD) to achieve diuresis of greater 
than 5 ml/min. was 42.8 (18.4) minutes. The mean time (SD) to return to baseline filling rate was 
124.5 (19.8) minutes. Based on these findings, the authors determined that pad application and 
exercising should take place between 60 and 120 minutes after the fluid load, as women are 
nearing their bladder capacity and, thus, are more likely to leak urine. Other investigators 
concluded that urine load (starting volume and diuresis) needed to be included in the analysis for 
the most accurate results.72,184 
Another study investigated whether a fixed bladder volume increased the accuracy of pad 
testing.75 Thirty-three women (mean age 56 years; range: 38-83) with SUI had their bladders 
infused to 75% of urodynamic capacity, and then performed a 12- to 15-minute pad test. The 
volunteers then voided, their bladders were artificially refilled to 75% of capacity, and the test 
was repeated. The correlation between the amount of urine lost in the first and second tests was 
good (r=0.74, p<0.001), and the leakage was consistently greater in the second set of tests, a 
finding supported by others.74 No correlation was found between the amount of urine lost and the 
severity of UI, as judged by symptoms (Ingelmann-Sundberg severity score). The authors 
suggested that this lack of association was likely because the physical exertion required of the 
participants during the test exceeded that of their daily activities and that intolerance of small 
amounts of leakage varies widely and is highly subjective, making grading difficult. 
Based on the studies from the 1980s investigating various aspects of a short pad test protocol, 
the ICS established guidelines in 1988 for pad testing to ensure standardisation, practicality and 
repeatability (See Table 2.1 for the details of all of the pad tests discussed.).1 The guidelines 
include test length (1 hour), amount and type of fluid drunk (500 ml of sodium-free liquid), 
activities performed, and type of statistical analysis to be used (nonparametric, as the results are 
not normally distributed). However, by the early 1990s, Hahn and Fall73 developed their own pad 
test, with four goals: that it be provocative enough to demonstrate mild SUI, be quick, so as to 
minimize variations due to diuresis, correlate well with the woman’s history, and be easy to 
perform. Fifty women with SUI who were referred for surgery (mean age 52 years; range 30-79; 
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parity not reported) performed the pad test with a fixed bladder volume, which was repeated one 
to seven days later. The two separate tests were highly correlated (r=0.94, p<0.001) and the pad 
test was highly sensitive, with no false-negatives. The authors suggested that testing should all be 
done by one investigator to standardise investigations as closely as possible, and that all tests 
should be done at the same time of day and same phase of menstrual cycle, to minimize sources 
of error. 
Around the same time, Petros and Ulmsten78 also developed a pad test that was more 
aggressive than the ICS test. Forty-six women referred to a gynaecology practice (mean age 43 
years; range 24-67; mean parity 3; range 1-7) started with 300 ml in the bladder and performed a 
series of exercises over the next 3-4 minutes. Intravesical pressure was also measured during the 
different activities and the results indicated an approximate linear relationship between 
intravesical pressure and urine loss. The authors justified the development of a new pad test by 
arguing that the ICS test does not precisely define what it is trying to measure: SUI or urge UI, 
which is “the complaint of involuntary leakage accompanied by or immediately preceded by 
urgency.”1 Differentiation between the two types of UI is clinically very important, as the 
aetiology, and thus treatment, of each problem varies considerably. In addition, the authors 
argued that the majority of the ICS test activities generate low bladder pressures (e.g. stepping, 
bending, coughing), versus the high pressures of jumping on a trampoline, thus representing only 
those women with severe SUI. Of the 38 women with SUI symptoms, 34 had a positive pad test 
and the authors suggested that even the trampoline test could not generate sufficient pressure to 
provoke SUI in all patients who reported leakage with a sneeze. 
Most recently, Rimstad et al.154 also increased the load of their pad test. One hundred and 
forty-seven women with SUI presenting to the obstetrics and gynaecology department for 
incontinence investigations underwent progressively more challenging tests, starting with a 
cough stress test in supine, then jumping jacks, and finally jumping jacks on a small trampoline. 
The trampoline test was able to document SUI in all except one woman (99%), while the 
jumping test captured 136 (93%), and the supine test 72 women (49%). Repeatability of the 
trampoline test was tested a few minutes after the first in 19 women (r=0.80, p-value not 
reported), with greater leakage during the second test (p=0.04).  
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Table 2.1: Pad Test Protocols 
Authors Test length! Drink or retrograde filling! Volume in bladder! Activities!
ICS (Abrams et al, 
1988)1!
1 hour Drinks 500 ml sodium-free 
liquid 
Unknown Walk, including stair-climbing one flight up and 
down (30 min.);  
Stand up from sitting (10 X); 
Cough vigorously (10 X); 
Run on the spot (1 min.); 
Bend to pick up object from floor (5 X); 
Wash hands in running water (1 min.)!
Hahn et al., 199173! 5 min.! Retrograde filling! 50% of bladder capacity! Climb up and down 100 steps; 
Cough vigorously (10 X);  
Run on spot (1 min.);  
Wash hands in running water (1 min.);  
Jump feet together (30 sec.);  
Jumping jacks (30 sec.) 
Petros et al., 199278! 3-4 min.! Retrograde filling! 300 ml! Cough (10 X);  
Pick up pen up from the floor (10 X);  
Wash hands in running water (30 sec.);  
Step up and down a step (20 X);  
Star/scissor jumps (10 X);  
Jump on a mini-trampoline (10 X)!
Persson et al., 200177! 1 min.! Retrograde filling! 300 ml! Jumping jacks (20 X);  
Run on the spot with high knees (20 X);  
Jump up and down (20 X)!
Morin et al., 2004151! 20 min.! Drink 1 litre water (control 
group) 
 
Retrograde filling (SUI)!
> 250 ml (confirmed by 
ultrasound) 
 
250 ml!
Walk, including stair-climbing one flight up and 
down (10 min.);  
Stand up from sitting (10 X);  
Cough vigorously (10 X);  
Run on the spot (1 min.); 
Bend to pick up object from floor (5 X);  
Jumping jacks (10 X);  
Wash hands in running water(1 min.) !
Rimstad et al., 2013154 3-4 min. Retrograde filling 300 ml Cough vigorously in supine and standing (3 X) 
each; 
Jumping jacks (20 X); 
Cough vigorously standing on trampoline (3 X); 
Jumping jacks on trampoline (20 X) 
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Several authors have attempted to shorten the one-hour pad test, for the benefit of the woman, 
the investigator, and to decrease the impact on health care spending.77,78,154,182 Persson et al.77 
recruited 47 parous women who had presented to the obstetrics and gynaecology office for 
urinary incontinence concerns (median age 49 years; range 29-64) to perform a short pad test 
with retrograde bladder filling to 300 ml. The test was repeated 5-10 minutes later with good 
reproducibility (median urine loss 8.5 ml; range 0±60 ml; p=0.26). The bulk of the evidence 
suggests that shortening the pad test does not decrease its reproducibility, therefore making these 
tests good options for assessing urine loss. 
Most of the above studies were performed in specialists’ offices and used retrograde filling 
during their pad test. While retrograde filling can increase the accuracy of the pad test,74 the 
procedure requires specialized equipment and technicians, which are both expensive and 
potentially difficult to access. Furthermore, this type of bladder filling compared to the natural 
filling following fluid consumption, may be less acceptable to women and poses the potential 
risk of introducing a urinary tract infection.  
A more recent study by Morin et al.151 used a dual-stream approach to bladder filling: the 
women with SUI had their bladders artificially filled to 250 ml, while the women without SUI 
drank one litre of water one hour prior to testing, with bladder volume (at least 250 ml) 
confirmed with ultrasound. Eighty-nine parous women presenting to an obstetrics and 
gynecology clinic (range 21-44 years) participated in the study using a modified 20-minute pad 
test to quantify and verify the symptoms of SUI. Fifty-nine women reported symptoms and 30 
were symptom-free. The pad test demonstrated high sensitivity and specificity, with all 
symptomatic women and none of the asymptomatic women leaking during the pad test. 
Several researchers have compared the one-hour pad test to other methods for objectively 
assessing urine leakage.68,77,184 Jorgensen et al.184 compared it to a standing cough stress test, and 
voiding cystourethrography: a technique for observing SUI on fluoroscopy. The pad test was 
found to be the most accurate for correctly diagnosing SUI (34/49 participants), followed by the 
stress test (17/49) and finally, by the voiding cystourethrography (16/49). The latter two tests 
produced false negatives approximately 50% of the time. Persson et al.77 also compared their pad 
test to the standing cough stress test and it was, again, found to be more sensitive (92% versus 
74%; p=0.05). Others have compared the results obtained from one-hour pad tests with 24 and 
48-hour pad tests. For the most part, weak or no correlation has been found between the two 
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types of pad test.174,187 These findings are not surprising as the longer pad tests measure the 
leakage provoked by an individual’s typical daily activities, whereas the shorter test is more 
likely to reflect the competence of the urethral sphincter by challenging the full bladder to 
withstand increased IAP.177  
A South Korean study investigated whether incontinence severity as measured by a one-hour 
pad test correlated with urethral mobility, leak point pressure and maximum urethral closure 
pressure in 274 women.76 Leak point pressure was the only urethral parameter correlated with 
the severity of SUI, with a weak inverse correlation to pad test weight (r=-0.383, p<0.005). In 
addition, the low leak point pressure group had greater urine loss on pad testing than the higher 
leak point pressure group (p<0.05), thereby significantly predicting the objective severity of SUI. 
Based on their findings, the authors suggested that the pad test should be considered one of the 
most important tests for the evaluation of women with UI. The relationship between subjective 
severity of UI and pad tests has also been investigated. Frazer et al.158 compared the severity of 
UI assessed with a self-reported visual analogue scale and a 2-hour pad test and found no 
correlation between the two. They reported that most subjects stated that the pad test was true 
reflection of their UI and argued that the lack of correlation related to subjective variability in the 
participants’ perception of the severity of their UI, not to weaknesses in the pad test. 
Despite the establishment of the ICS guidelines for pad testing in 1988,1 a systematic review 
from 2002 found that, out of the 75 papers evaluated, only 25 reported using the guidelines.180 In 
fact, how the pad tests were conducted and reported varied so much in the studies reviewed that 
it was difficult to compare them and to interpret the differences. For tests performed in the clinic, 
for example, there were differences in the starting bladder volume or the amount drunk, the 
activity schedule and the length of the test. Although not presented in the systematic review, 
some past explanations for altering the ICS protocol include: shortening the testing time, 
improving accuracy, limiting the test to SUI only, and increasing ease of performance.70,73,78,80,154 
The recommendations of the systematic review included that the ICS guidelines should be 
reviewed and revised, and that further development and validation are needed to produce pad 
tests which are clinically significant, realistic, practical to perform and relevant to women with 
SUI. Another systematic review supports these recommendations,53 but to date, no such revision 
has been published. 
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In summary, home-based pad tests assess the incontinence experienced during activities of 
daily living, and they are not meant to be provocative. These longer tests are unable to 
differentiate between stress and urge UI, and are difficult to standardise. Short pad tests provide 
one way for clinicians to assess the symptoms of urinary incontinence. The tests are non-
invasive, easy to perform, provide immediate results, and allow the clinician to limit the 
activities associated with SUI only. However, no such test has been developed for young, healthy 
women with SUI. 
2.5 Conclusion 
Effective treatment for SUI requires that clinicians understand the severity of the problem and 
the underlying deficits. Office-based pad testing is the only one of the aforementioned 
measurement procedures that can quantify small and large amounts of urine loss. Having an 
adequate measure for SUI severity such as the pad test, will assist clinicians to improve their 
ability to diagnose SUI causes. In a study that presented case studies to specialists in the United 
Kingdom, the authors concluded that pad test outcomes did influence treatment planning.189 For 
both clinical application and future research, identifying a pad test sensitive to treatment 
interventions will help to improve patient care.  
Based on the literature review, no pad test protocol exists for young, nulliparous women with 
SUI. SUI in young, nulliparous women is a serious problem and an appropriate tool for assessing 
symptom severity is lacking. The current literature of incontinence assessment tools has been 
studied in older parous women, approximately 50 years of age. In addition, most of the protocols 
include hand washing, an activity used to elicit urge UI, which is an exclusion criterion in the 
present study. This SUI-specific pad test was created to be more aggressive than previously 
published tests, to challenge the young pelvic floor. It was hypothesized that this novel pad test 
would demonstrate good reliability83 and specificity in young, healthy women between the ages 
of 18 and 30 years.
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CHAPTER 3 
METHODOLOGY 
Ethics approval for the study was received from the University of Saskatchewan Biomedical 
Research Ethics Board (BioREB 12-179). Volunteers were recruited via advertisements posted 
across the university campus and on the online student portal. Potential volunteers contacted the 
researcher by email or telephone and they were screened for inclusion by telephone. The 
screening questionnaire (Appendix B) included the 3 Incontinence Questions (3IQ);189 and 
questions about oral contraceptive use and history of pregnancy. Inclusion criteria were female, 
between the ages of 18 and 30, and able complete twenty minutes of vigorous physical activity. 
Those who reported symptoms of SUI were in the experimental (incontinent) group and those 
who had no UI were part of the control (continent) group. Women who reported symptoms of 
urge incontinence were excluded from the study. Each volunteer was provided with the Research 
Participant Information Sheet (Appendix C) for review prior to the first appointment.  
Methods, definitions and units conform to the standards recommended by the International 
Urogynecological Association and the International Continence Society joint report on the 
terminology for female pelvic floor dysfunction57 and the standards of documentation in pad test 
reporting.180 
Preliminary pad testing was based on the pad test protocols of Bø182 and Morin et al.81 
(Appendix A). 
3.1 Pad Test Protocol 
Participants were instructed to wear appropriate exercise clothing (e.g. t-shirt, shorts and 
running shoes) to the testing sessions. One hour prior to testing, each participant was asked to 
drink one litre of water and not to empty her bladder until after the testing procedure was 
complete. Upon arrival for testing, the Research Participant Information Sheet (Appendix C) was 
reviewed, any questions were answered, and the consent form was signed. Next, the woman’s 
height and weight were measured. She was then given a pre-weighed (Mini Digital Scale, 
Chestnut Tools, Almonte, ON) brown paper bag containing one incontinence pad and a plastic, 
resealable bag. The scale was accurate to one gram and to improve the reliability of bag weights, 
each bag was weighed three times. If there was discrepancy between the weights, the mode was 
recorded. The volunteer was asked to place the pad in her underwear in the privacy of a 
bathroom, keeping all the pad wrappings in the paper bag. The pad test was then performed. 
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Following the pad test, the participant was permitted to void and instructed to place the pad in 
the plastic bag, putting it, along with the wrappings, into the paper bag. The paper bag was then 
re-weighed. To test repeatability, the pad test was performed on two consecutive days, at 
approximately the same time each day (within 2 hours) to minimize confounding influences, 
such as fatigue and differences in fluid consumption (e.g. coffee, tea). 
Each woman was instructed to perform the activities in the pad test protocol with maximal 
effort. She was encouraged to not prevent any leakage from happening, either by slowing or 
stopping the activity, or by contracting her pelvic floor muscles. If the participant needed rest in 
between activities, she was given as much time as required.  
For a warm-up, the volunteer walked up and down 40 steps at her own pace, after which the 
pad test was performed. The pad test started with the participant running up and down 40 steps 
twice (80 steps), taking approximately one minute; and then completing 1 minute intervals each 
of the following activities:  
• standing up from sitting; 
• sit-ups/curl-ups with feet on plinth;  
• running on the spot, 
• jumping jacks; 
• jumping on a 100 cm diameter exercise trampoline (Tempo Fitness); 
• 10 vigorous coughs. 
The participants were offered standardised encouragement at 30 and 50 seconds for each of 
the timed tests. 
3.2 Statistical Analyses 
Data were analyzed statistically using Minitab 16 and SPSS Statistics 21 software. A ranked 
repeated measures ANOVA was used to evaluate differences between the continent and 
incontinent groups and the testing sessions. The model included continence status and the testing 
session as fixed factors and the participant as a random factor. The interaction between 
continence status and testing session was included in the model. Intraclass correlation 
coefficients (ICCs), two-way mixed effects model, were computed for each group to estimate 
how closely the data from each participant matched from day one to day two.  
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CHAPTER 4 
RESULTS 
Sixteen nulliparous women aged 22 to 29 years (mean: 26.06±2.08) participated in the study. 
Participant demographics are presented in Table 4.1. The mean body mass index (BMI) for the 
sample was 21.88 kg/m2 (±1.92, range 19.4-25.5). Seven of the volunteers were continent 
(controls) and nine had SUI. Seven women (3 with SUI; 4 controls) were using hormonal 
contraceptives. There were no dropouts and all the participants completed the testing without 
incident.  
Table 4.1: Participant demographics 
 Age (years) 
(mean±SD) 
Weight (kg) 
(mean±SD) 
Height (m) 
(mean±SD) 
BMI (kg/m2) 
(mean±SD) 
Continent (n=7) 25.71 ± 2.27 64.93 ± 5.11 1.75 ± 0.08 21.20 ± 1.78 
SUI (n=9) 26.33 ± 1.94 61.27 ± 8.08 1.65 ± 0.05 22.36 ± 1.86 
Total (n=16) 26.06 ± 2.08 62.87 ± 6.99 1.70 ± 0.08 21.88 ± 1.92 
 
The mean increase in pad weight for both testing sessions was 0.64 g (±0.50) in the continent 
group and 11.89 g (±20.32) in the group with SUI. The repeated measures ANOVA found that 
the interaction between testing session and continence status was not significant (p=0.721), nor 
was there a change in pad weight between the testing sessions (p=0.228). Pad weights between 
the two groups of women were significantly different (p=0.023).  
Intraclass correlation coefficients (ICCs) were computed for each group, using a two-way 
mixed effects model, to estimate how closely the data from each participant matched from day 
one to day two. The ICC for the continent group was 0.845 (95% CI: 0.139–0.973) and 0.782 
(95% CI: -0.040–0.952) for the group with SUI.  
The test was unable to elicit measurable urine loss in three participants with SUI, resulting in 
three false negatives.
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Figure 4.1: Pad weight and continence status.  
Differences in pad weight by testing session and continence status. Bars indicate mean change in 
pad weight and whiskers indicate the 95% CI of the mean. 1= first testing session; 2 = second 
testing session; * indicates a significant difference (p=0.023). 
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CHAPTER 5 
DISCUSSION 
The purpose of this pilot study was to determine the reliability and accuracy of a new, 
standardised pad test designed specifically to assess urine leakage in young, healthy women with 
SUI. The findings from this study indicate that this novel pad test is reliable and can differentiate 
between young, nulliparous women with and without SUI. This new pad test has excellent 
potential for clinical use in younger women, as it is more provocative than previous pad tests. 
5.1 Methodology 
One of the strengths of this study was that it was designed to address a population that is 
under-represented in the SUI literature. The majority of the women who have participated in past 
research relating to SUI have presented to a clinic, often a surgeon’s office, seeking treatment for 
their SUI. In addition, most of those women were older than 30 years and were parous. The 
women who volunteered for this study were nulliparous, under the age of 30, and represent a 
younger female population with SUI symptoms, not being followed or identified within the 
health care system. Indeed, women who are symptomatic with SUI but have not presented to 
their health care provider represent the majority, 80.2% according to one study.20 These 
differences in study populations may also represent variation in the pathophysiology of the SUI 
symptoms and also, potentially, severity. 
This study was conducted using a novel pad test because preliminary testing (Appendix 
A) found that previously published pad tests were not challenging enough to elicit urine leakage 
in young, nulliparous women.151 The preliminary study did not provoke any significant 
difference in urine leakage between the women with and without incontinence in this population. 
This novel pad test incorporated several important modifications from other protocols in order to 
develop a more sensitive tool that was specific to SUI, and to address population-specific 
concerns, not previously addressed in the literature. Hand washing, which is used to elicit urge 
incontinence, was removed from the protocol to make this test more specific to SUI.  The fluid 
load was increased to one litre from the 500 ml recommended in the ICS guidelines based on the 
findings of the Haylen et al.186 study from 1988, which concluded that pad application and 
exercising should take place between 60 and 120 minutes after the one litre fluid load, as women 
are nearing their cystometric capacity, and are more likely to leak urine. Unlike Morin et al.,151 
we did not have the tools readily available to scan the bladder, but based on previous literature 
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and participants’ spontaneous comments, their bladders should have been full. Finally, the 
activity schedule was changed by increasing the duration of the tasks and by adding jumping on 
a trampoline, as the original activities were deemed not to be provocative enough to elicit SUI in 
these young women. Both Petros and Ulmsten78 and Rimstad et al.154 added mini-trampolines to 
their activity protocols, suggesting that the pressures generated while jumping on the trampoline 
might be closer to those generated by sneezing.78 
5.2 Between Group Testing 
 Pad weight was found to be significantly different between groups. The pad weight gain 
in the group with SUI was less than pad weight changes reported in other studies.70,185 The range 
of mean urine loss reported in the literature varies from 17 to 54 g,70,72-74,81,154,184,185 with the 
highest losses reported for a population of women referred for SUI surgery.73 When comparing 
the volunteers from this study to other study populations, ours is younger and did not present at a 
clinic for assessment of SUI symptoms, potentially accounting for the smaller amount of mean 
urine loss. 
All of the asymptomatic women had a pad weight gain of less than 1 g, so there were no 
false positives. This small change in pad weight suggests that, under indoor, climate-controlled 
conditions, the test did not stimulate significant vaginal secretions or perspiration. Furthermore, 
it suggests that any pad weight gain of greater than 1 g can be interpreted as quantifiable 
incontinence. These findings fit with the recommendations in a review of pad testing, which 
proposed that the upper limit for pad weight gain in an asymptomatic woman, should be between 
1.0 and 1.4 g.179  
Leakage was not quantifiable in three women who reported symptoms of SUI. This does 
not indicate that the participants did not leak at all, rather that their leakage was less than 1 g. 
This amount of SUI might still be bothersome, but would not be enough to be quantified with 
this test. Alternately, as was proposed by Petros and Ulmsten,78 it is possible that the forces 
generated during the testing procedures were not sufficient to replicate those forces produced 
during very provocative actions of daily life, such a sneeze, or high impact physical activities. In 
addition, some women may only experience SUI when their PFMs are fatigued, and it is possible 
that the pad test did not tire the PFMs sufficiently to compromise the continence mechanism in 
three volunteers. Phases of the menstrual cycle have also been associated with changes in SUI 
symptoms, and may represent another potential reason for negligible urine loss.190,191  
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Three of 46 women in the Petros and Ulmsten78 study did not lose urine in their pad test, 
and to address this problem, the authors had the participants repeat the trampoline jumping to 
further challenge the continence mechanism. While this additional test promoted SUI in all 
participants, the pad test then lacked standardisation. In another study by Persson et al.,77 3 of 34 
women did not leak during the pad test. The population of women in both of these studies was 
older, parous and had presented to a clinic for assessment of SUI symptoms. These 
characteristics suggest that the pathophysiology of the SUI was different and potentially more 
severe, thereby having a lower percentage of false negatives compared to the current study.  
5.3 Day-to-Day Repeatability 
The novel pad test presented here provoked similar amounts of urine loss on the two 
consecutive testing days, demonstrated by the high ICCs for each group, which are similar to 
correlation coefficients found in studies using other pad tests.70-73,75,184 One needs to interpret the 
ICCs with caution however, as the confidence intervals are wide, which is consistent with other 
studies.71,192 This is likely due, in part, to the small sample size of this pilot study, but also with 
the variability in the amount of leakage between women.  
There was a trend (5/9 women) towards greater leakage on day two in the symptomatic 
group, which is consistent with several other studies.74,75,154,192 Some of the reasons for this trend 
may include: neuromuscular fatigue, increased effort, physiological relaxation, and/or 
psychological relaxation.75,77,192 The clinical implication of increased leakage on a second test is 
that the test may always need to be done twice to get an accurate measure of leakage.  
5.4 Implications for Practice 
 It has been well-established that SUI in young nulliparous women is a serious problem 
and that an appropriate tool for assessing and quantifying leakage is lacking. This study could 
have far-reaching clinical implications as this new pad test could be utilized and integrated into 
the management practices of UI specialists, including physical therapists, gynecologists, nurses, 
and other health care providers. Given that existing one-hour pad test results influence change of 
management practices (e.g. surgical versus non-surgical intervention),188 a more accurate test for 
young nulliparous women could have substantial benefit in directing treatment. This novel pad 
test could be used to determine the minimally clinically important changes occurring with 
various interventions for women with SUI. As research shows there is a higher incidence of SUI 
in elite athletes, our pad test could also be used to investigate SUI in young athletes. It also might 
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prove valuable in assessing the temporal fluctuations in urine leakage in young, healthy women, 
such as during different stages of the menstrual cycle. 
5.5 Limitations 
 There are a few limitations of the study that should be noted and considered for future 
research. First, as this was a pilot study, the sample size was small. Small samples affect the 
variation of the data to have greater impact on statistical power; however despite the small 
sample size, a significant difference was found. A larger sample may be more representative of 
the population studied. Second, three false negatives were revealed, possibly suggesting that the 
test was not challenging enough to stress the continence mechanism, or that it provoked less than 
1 g of urine loss. Last, during this project we did not assess bladder volume prior to the pad test. 
While all the women expressed that their bladders felt very full, this was not quantified. 
Differences in starting urine volume between testing sessions could negatively affect the test-
retest repeatability.  
5.6 Conclusions and Recommendations 
5.6.1 Conclusions 
The purpose of this pilot study was to determine the reliability and accuracy of a new pad 
test to evaluate SUI in young, healthy women. It can be difficult to provoke urinary leakage in 
healthy young women, despite self-reports of SUI. This challenge is likely because they have 
experienced little damage to their pelvic floors, such as through parity, ageing and elevated 
BMIs, and that their leakage is usually triggered by relatively high intra-abdominal pressure. The 
results of this study support the use of this pad test in healthy young women with SUI; it appears 
to be challenging enough to cause measureable urine loss in the majority, including those with 
low BMI, and it may be useful for diagnosing and quantifying SUI without urodynamic studies. 
5.6.2 Further research suggestions:  
Based on this study, a number of recommendations can be made for further research: 
i. Increasing the study sample size would provide more accurate estimates of the 
typical amount of urine leakage experienced by a broader representation of SUI 
severity, 
ii. Investigating how many repetitions of the pad test are required until the leakage 
stabilizes,  
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iii. Methods to assess small, but bothersome amounts of leakage should be tested in 
this population. For example, participants might take riboflavin supplements with 
their fluid load to colour their urine,78 or oral phenazopyridine to differentiate urine 
from other body fluids.193 
iv. Methods to improve the assessment of the starting bladder volume, such as 
transabdominal ultrasound, could be added to further standardise the test protocol, 
thereby improving day-to-day repeatability. 
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APPENDIX A 
PRELIMINARY TESTING DATA 
Table A.1 Descriptive Statistics for Preliminary Pad Test 
 Age (years) 
(mean) 
Weight (kg) 
(mean) 
Height (m) 
(mean) 
BMI (kg/m2) 
(mean) 
Pad weight (g) 
(median, range) 
Continent 
(n=7) 
25.43 63.90 1.70 22.16 0, 0-1 
SUI (n=6) 27.00 71.73 1.68 25.45 1, 0-2 
Total (n=13) 26.15 67.52 1.69 23.68 1, 0-2 
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APPENDIX B 
SCREENING QUESTIONNAIRE 
 
Instructions: This questionnaire can be administered by the research co-ordinator in person 
or over the phone.  
Thank you for considering taking part in our study assessing a new pad test for young, healthy 
women with urinary leakage. The following questions help us to determine if you are eligible 
for this study and include questions about urinary leakage, your level of physical activity and 
use of medications. It will take approximately 2 minutes to complete. You are not obligated to 
answer any questions that you are not comfortable with. 
 
Date of birth: __________________ 
 
Please answer the following questions to the best of your knowledge: 
1. During the last 3 months, have you leaked urine (even a small amount)? 
!Yes  !No 
 
2. During the last 3 months, did you leak urine: 
(check all that apply) 
!  a)  When you were performing some physical activity, such as coughing, sneezing, 
lifting or exercise? 
!  b)  When you had the urge or the feeling that you needed to empty your bladder, but 
you could not get to the toilet fast enough? 
!  c)  Without physical activity and without a sense of urgency? 
 
3. During the last 3 months, did you leak most often: 
(check only one) 
!  a)  When you were performing some physical activity, such as coughing, sneezing, 
lifting or exercise? 
!  b)  When you had the urge or the feeling that you needed to empty your bladder, but 
you could not get to the toilet fast enough? 
!  c)  Without physical activity and without a sense of urgency? 
!  d)  About equally as often with physical activity as with a sense of urgency?
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4. Is there any reason that you might not be able to complete 20 minutes of physical 
activity, including running up and down stairs, jumping jacks, sit-ups and coughing? 
! Yes   ! No 
If yes, please explain: ____________________________________________ 
_______________________________________________________________   
 
5. Are you taking any hormonal contraceptives such as: oral contraceptives (“the pill”), 
injection (Depo-Provera), patch (Ortho-Evra) or IUD (Mirena)? 
! Yes   ! No 
 
6. Have you been pregnant for longer than 20 weeks? 
! Yes   ! No 
 
7. What is your preferred method of communication for booking appointments? 
! Phone 
! Email 
 
8. Would you be willing to be contacted for future studies related to pelvic floor and 
incontinence research? 
!  Yes   ! No 
 
9. Next appointment for reviewing consent form: ____________________________ 
 
 
 
Thank you for your time. 
If you have any questions, please call Juliet at the School of Physical Therapy 
(University of Saskatchewan) 
Email: juliet.sarjeant@usask.ca 
Tel: 306-966-8619 
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APPENDIX C 
RESEARCH PARTICIPANT INFORMATION SHEET 
 
 
 
Research Participant Information Sheet 
 
Development of a pad test to assess stress urinary incontinence in 
young, healthy women: a pilot project 
 
 
 
Scientific Investigator:   Student Research Co-ordinator: 
Stéphanie Madill  PhD1  Juliet Sarjeant  MSc Candidate1  
Phone: 306-966-6570  Phone: 306-966-8619 
Email: stephanie.madill@usask.ca  Email: juliet.sarjeant@usask.ca 
 
Scientific Co-investigators:  
Cathy Arnold  PhD1 
Phone: 306-966-6588 
Email: cathy.arnold@usask.ca 
 
 
Emergency Telephone Number: 306-966-6570  
 
 
1School of Physical Therapy, College of Medicine, 1121 College Drive, University of Saskatchewan, Saskatoon, 
Saskatchewan, Canada 
 
Study Location: School of Physical Therapy
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Introduction:  
You are invited to take part in a research study in the School of Physical Therapy at the 
University of Saskatchewan because you responded to the request for participants and have 
undergone the telephone screening process. Please read the following information sheet and ask 
as many questions as necessary before you decide whether to participate. Please take the time to 
read the information carefully and to discuss it with your family, friends or doctor before you 
decide whether or not to take part.  
 
Your participation is voluntary. It is up to you to decide whether or not you wish to take part. If 
you decide to participate, you are still free to withdraw at any time and without giving any 
reasons for your decision. If you do not wish to participate, it will not affect your academic 
standing, employment or medical care, as applicable. 
 
Funding to cover the costs of conducting this study has been provided by the University of 
Saskatchewan. The researchers are not receiving any financial gain from conducting this study. 
 
Why is this study being done? 
Stress urinary incontinence (SUI) is the involuntary leakage of urine with coughing, laughing, 
sneezing or vigorous physical activity. Anywhere between 7 and 16% of women between the 
ages of 18 and 30 experience SUI. In female college athletes, the incidence of SUI rises to 49%.  
  
Pad tests are simple tests that use a self-adhesive pad in a woman’s underwear to measure urine 
leakage over a set amount of time or with a set amount of activity. A pad test is not invasive, it is 
easy to administer, cost effective, and can diagnose incontinence and determine its severity. 
However, most pad tests are used to assess SUI in older women who had had babies. Such tests 
are not likely to be vigorous enough to elicit leakage in healthy, young women who have not had 
babies.  
 
The purpose of this study is to develop a new tool to measure urine leakage in young, healthy 
women with SUI. We will be collecting information from twelve (12) volunteers. Should this 
tool be effective in testing SUI in young women, we will use it in another study investigating the 
effects of the menstrual cycle on urinary leakage. Together, the results of these studies may lead 
to changes in the way researchers and health care professionals test young women with SUI, 
which may lead to improvements in treatment for these women. 
 
Who can participate in the study? 
Women who are eligible for this research must: 
• be between the ages of 18 and 30 
• be able to complete twenty (20) minutes of vigorous physical activity: running on the 
spot, standing up from sitting, running up and down stairs, sit-ups, jumping jacks, 
jumping on a small trampoline and vigorous coughing. 
 
 
What does the study involve? 
This study will involve collecting data on two (2) consecutive days for approximately twenty 
(20) minutes each.  
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First testing session: All testing will be performed by the research co-ordinator, a female 
physiotherapist with ten (10) years of clinical experience. The test procedure will be thoroughly 
explained before starting the test.  
 
You will be asked to come to the School of Physical Therapy for twenty (20) minutes of testing. 
Testing may be done individually or in a group setting. You will be asked to drink one (1) litre of 
water one (1) hour prior to the test start time. It is important that you do not empty your bladder 
between the time you drink the water and the end of the testing session. We encourage you to 
wear or bring appropriate running shoes and a t-shirt and shorts. 
 
The pad test involves performing twenty (20) minutes of physical activity (running on the spot, 
standing up from sitting, running up and down stairs, sit-ups, jumping jacks, jumping on a small 
trampoline and vigorous coughing) while wearing a self-adhesive pad that you will place in your 
underwear, like a menstrual pad. This pad will be weighed before and after the test to determine 
the amount of urine loss. 
 
Second testing session: The pad test will be repeated the following day at a mutually convenient 
time. 
 
What are my responsibilities? 
As a study participant, you will be expected to:  
a. Follow the directions of the research co-ordinator; and 
b. Report any changes in your health to the research co-ordinator. 
 
What are the possible risks and discomfort? 
There is a small risk of physical injury from activities such as running up and down stairs, 
jumping on a small trampoline, performing jumping jacks and sit-ups. In order to address this, 
the environment for the pad test will be set up to minimize any risks and you will be given an 
opportunity to warm up prior to the vigorous activities. Wearing appropriate running shoes, 
shorts and a t-shirt will also decrease any chance of injury.  
 
What are the benefits of participating in this study?  
There are no guaranteed benefits for you from participating in this study. We believe that the 
information gained from this study will improve our knowledge about SUI so that assessment 
and treatment strategies can be enhanced to benefit other women with SUI.  
 
What if new information becomes available? 
If, during the course of the study, new information becomes available that may be related to your 
health or your willingness to participate, this information will be provided to you by the research 
co-ordinator.  
What will the study cost me? 
You will not be charged for any research-related procedures. You will not be paid for 
participating in this study. Reimbursement for study-related expenses (e.g. travel, parking, 
meals) is not available.  
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Will my participation in this study be kept confidential? 
In Saskatchewan, the Health Information Protection Act (HIPA) defines how the privacy of your 
personal health information must be maintained so that your privacy will be respected. Your 
name will not be attached to any information, nor mentioned in any study report, nor be made 
available to anyone except the research team. It is the intention of the research team to publish 
results of this study in scientific journals and to present findings at related conferences, 
workshops and in the Master’s thesis of the research co-ordinator, but your identity will not be 
revealed. 
 
What happens if something goes wrong? 
In the event of a research-related injury, you will need to seek immediate medical attention at no 
additional cost to you. You are not waiving your legal rights by agreeing to participate in this 
study.  
 
What happens after completion of the study? 
If desired, we will provide you with some information about SUI and a list of physiotherapists in 
Saskatoon specially trained to assess and treat women with SUI. 
  
Should you be interested, the results of the study will be provided to you, when they become 
available. 
  
What happens if I decide to withdraw? 
Your participation in this research is voluntary. You may withdraw from this study at any time. 
You do not have to provide a reason. If you choose not to participate in, or you withdraw from, 
the study, your future academic status and medical care will not be affected. If you wish to 
withdraw from the study, please notify the study personnel as soon as possible and the 
appropriate arrangements will be made.  
 
The study may be stopped or you may be removed from the study at any time. Reasons for this 
may include injury, failure to follow study instructions, administrative reasons or if the study 
investigators decide that it is in your best interest to withdraw you from the study.  
 
If you voluntarily withdraw from the study, or if you are withdrawn, and you do not want your 
data to be used in the study, please contact the study personnel and your data will not be used for 
research purposes.  
 
Questions/Contact Information:  
This study has been reviewed and approved on ethical grounds by the University of 
Saskatchewan Research Ethics Board (BIOREB 12-179 and date). The Biomedical Research 
Ethics Board is responsible for the protection of human participants involved in research studies. 
All study-related procedures will be performed in compliance with Good Clinical Practice 
guidelines set forth by Health Canada for the conduct of research with human participants.  
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If you have any questions regarding your participation in this study, please feel free to contact 
Juliet Sarjeant (MSc Candidate, Research Co-ordinator) at 306-966-8619 or Dr. Stéphanie 
Madill (Principal Investigator) at 306-966-6570. 
 
If you have questions about your rights as a research volunteer or concerns about the study, 
please contact the Chair of the Biomedical Research Ethics Board, c/o Ethics Office, University 
of Saskatchewan at 306-966-4053. Collect calls will be accepted.  
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Research Participant Consent Form 
Development of a pad test to assess stress urinary incontinence in young, healthy 
women: a pilot project 
 
I have read the attached Research Participant Information Sheet, and I freely and voluntarily 
agree to take part in this study. 
 
I understand the purposes and procedures and the possible risks and benefits of the study.  
 
I was given sufficient time and opportunity to ask questions and to reflect on my understanding 
of, and participation in, the study. My questions have been answered to my satisfaction.  
 
I agree to fully cooperate with the study personnel and will tell them of any injuries that I sustain 
during the study.  
 
I am free to withdraw from the study at any time, for any reason, and I am aware that this will 
not affect my future medical treatment.  
 
I give permission for the use and disclosure of my de-identified personal health information 
collected for the research purposes described in this form. 
 
I understand that by signing this document I do not waive any of my legal rights.  
 
I will be given a signed and dated copy of this consent form. 
 
I would like to receive a copy of the study results: 
  
❒  yes  ❒  no 
 
Participant Signature: ______________________________________________________ 
 
Participant Name (please print): _____________________________________________ 
 
Date: ___________________________  Time: ________________________ 
 
Investigator/Delegate Signature: _____________________________________________ 
 
Investigator/Delegate Name (please print): _____________________________________ 
 
Date: ___________________________  Time: ________________________ 
 
 
 
 
